Annual / Quarterly Financial Statement • Feb 27, 2023
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer



Línea Directa Aseguradora S.A.
| 1. REPORT OF THE EXTERNAL AUDITORS | 3. MANAGEMENT REPORT 2022 | |||
|---|---|---|---|---|
| 2. FINANCIAL STATEMENTS 2022 | Business performance | 89 | ||
| Financial position and equity | 89 | |||
| Balance sheets | 3 | Outlook for 2023 | 89 | |
| Statement of profit or loss | 5 | Information on deferred payments to suppliers | 90 | |
| Statement of recognised income and expense | 7 | Transactions with treasury shares | 91 | |
| Statement of changes in equity | 8 | Use of derivative financial instruments | 92 | |
| Statement of cash flows | 9 | Events after the reporting date | 92 | |
| Notes to the separate financial statements | 10 | Research and development | 92 | |
| Financial position and equity | 89 | |||
|---|---|---|---|---|
| Information on employees | ||||
| Claims and Consumer Ombudsman |
||||
| Other non-financial information | ||||
| Annual corporate governance report, IFCR and annual report on directors remuneration |
94 | |||
4. DRAFTING AND ATTESTATION




This version of our report is a free translation from the original, which was prepared in Spanish. All possible care has been taken to ensure that the translation is an accurate representation of the original. However, in all matters of interpretation of information, views or opinions, the original language version of our report takes precedence over this translation.
To the shareholders of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros
We have audited the annual accounts of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros (the Company), which comprise the balance sheet as at 31 December 2022, and the income statement, statement of changes in equity, cash flow statement and related notes for the year then ended.
In our opinion, the accompanying annual accounts present fairly, in all material respects, the equity and financial position of the Company as at 31 December 2022, as well as its financial performance and cash flows for the year then ended, in accordance with the applicable financial reporting framework (as identified in note 2 of the notes to the annual accounts), and in particular, with the accounting principles and criteria included therein.
We conducted our audit in accordance with legislation governing the audit practice in Spain. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the annual accounts section of our report.
We are independent of the Company in accordance with the ethical requirements, including those relating to independence, that are relevant to our audit of the annual accounts in Spain, in accordance with legislation governing the audit practice. In this regard, we have not rendered services other than those relating to the audit of the accounts, and situations or circumstances have not arisen that, in accordance with the provisions of the aforementioned legislation, have affected our necessary independence such that it has been compromised.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the annual accounts of the current period. These matters were addressed in the context of our audit of the annual accounts as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
PricewaterhouseCoopers Auditores, S.L., Torre PwC, Pº de la Castellana 259 B, 28046 Madrid, España Tel.: +34 915 684 400 / +34 902 021 111, Fax: +34 915 685 400, www.pwc.es

The Company engages in non-life insurance activities, mainly in the motor, home, and medical assistance lines, recognizing liabilities associated with insurance contracts that reflect the unearned premiums and provision for claims.
This last concept includes, among others, the estimated cost of claims pending settlement, payment and not reported, mainly in the motor line, amounting to 325.029 thousand euros as of December 31, 2022.
The Company uses statistical methods authorized by the Spanish insurance regulator to calculate the claim provision for the motor line, which reflects the estimated cost of the claims occurred until December 31, 2022. Such actuarial calculations, based on both generally accepted deterministic and stochastic techniques, are complex and incorporate judgments about assumptions made by management.
The calculation of the claim provision, given the nature of these liabilities, is a complex estimate that, in the case of the motor line, is significantly influenced by the projection methods, the settlement periods and the assumptions used by management, as well as the impact of the valuation of personal claims in accordance with applicable regulations. For these reasons, the valuation of motor insurance provision for claims is considered as a key audit matter.
See notes 2.c, 4.g and 10 of the 2022 annual accounts.
Key audit matters How our audit addressed the key audit matters
We gained an understanding of the Company´s process for estimating and registering the motor insurance provision for claims, which included understanding and evaluating the internal control process, the relevant IT systems, and the most relevant assumptions. Our procedures, in which we have engaged a team of actuarial specialists, have focused on aspects such us:
In our procedures above, we obtained sufficient appropriate audit evidence to support the estimates of management regarding this matter.

Other information comprises only the management report for the 2022 financial year, the formulation of which is the responsibility of the Company's directors and does not form an integral part of the annual accounts.
Our audit opinion on the annual accounts does not cover the management report. Our responsibility regarding the management report, in accordance with legislation governing the audit practice, is to:
On the basis of the work performed, as described above, we have verified that the information mentioned in section a) above has been provided in the manner required by applicable legislation and that the rest of the information contained in the management report is consistent with that contained in the annual accounts for the 2022 financial year, and its content and presentation are in accordance with applicable regulations.
Responsibility of the directors and the audit commission for the annual accounts
The directors are responsible for the preparation of the accompanying annual accounts, such that they fairly present the equity, financial position and financial performance of the Company, in accordance with the financial reporting framework applicable to the entity in Spain, and for such internal control as the aforementioned directors determine is necessary to enable the preparation of annual accounts that are free from material misstatement, whether due to fraud or error.
In preparing the annual accounts, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.
The audit commission is responsible for overseeing the process of preparation and presentation of the annual accounts.
Auditor's responsibilities for the audit of the annual accounts
Our objectives are to obtain reasonable assurance about whether the annual accounts as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion.
Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with legislation governing the audit practice in Spain will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic

decisions of users taken on the basis of these annual accounts.
As part of an audit in accordance with legislation governing the audit practice in Spain, we exercise professional judgment and maintain professional scepticism throughout the audit. We also:
We communicate with the entity's audit commission regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide the entity's audit commission with a statement that we have complied with relevant ethical requirements, including those relating to independence, and we communicate with the aforementioned those matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
From the matters communicated with the entity's audit commission, we determine those matters that were of most significance in the audit of the annual accounts of the current period and are therefore the key audit matters.
We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter.
European single electronic format
We have examined the digital file of the European single electronic format (ESEF) of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros for the 2022 financial year that comprises an XHTML file of the annual accounts for the financial year, which will form part of the annual financial report.

The directors of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros are responsible for presenting the annual financial report for 2022 financial year in accordance with the formatting requirements established in the Delegated Regulation (EU) 2019/815 of 17 December 2018 of the European Commission (hereinafter the ESEF Regulation). In this regard, the Annual Corporate Governance Report and the Annual Report on Directors' Remuneration have been incorporated by reference in the management report.
Our responsibility is to examine the digital file prepared by the Company's directors, in accordance with legislation governing the audit practice in Spain. This legislation requires that we plan and execute our audit procedures in order to verify whether the content of the annual accounts included in the aforementioned file completely agrees with that of the annual accounts that we have audited, and whether the format of these accounts has been affected, in all material respects, in accordance with the requirements established in the ESEF Regulation.
In our opinion, the digital file examined completely agrees with the audited annual accounts, and these are presented, in all material respects, in accordance with the requirements established in the ESEF Regulation.
Report to the audit commission
The opinion expressed in this report is consistent with the content of our additional report to the audit commission of the Company dated 24 February 2023.
Appointment period
The General Ordinary Shareholders' Meeting held on 24 March 2022 appointed us as auditors for a period of one year, for the year ended 31 December 2022.
Previously, we were appointed by resolution of the General Ordinary Shareholders' Meeting for a period of tres years and we have audited the accounts continuously since the year ended 31 December 2016.
Services provided
Services provided to the audited entity and its subsidiaries for services other than the audit of the accounts are disclosed in note 22.e) to the annual accounts.
PricewaterhouseCoopers Auditores, S.L. (S0242)
Enrique Anaya Rico (23060)
24 February 2023


Annual financial statements and management report for the year ended 31 December 2022
Prepared in accordance with the Chart of Accounts of Insurance Entities
The English version is a translation of the original in Spanish for the information purposes only. In case of discrepancy, the Spanish version shall prevail.
(in thousand euro)
| ASSETS | Notes | 2022 | 2021 (*) | |
|---|---|---|---|---|
| A.1 | Cash and cash equivalents | Notes 8 and 9 | 44,040 | 98,911 |
| A.2 | Financial assets held for trading I. Equity instruments |
- - |
- - |
|
| II. Debt securities | - | - | ||
| III. Derivatives | - | - | ||
| IV. Other | - | - | ||
| A.3 | Other financial assets at fair value through profit or loss I. Equity instruments |
- - |
- - |
|
| II. Debt securities | - | - | ||
| III. Hybrid instruments IV. Investments for the benefit of life-assurance policyholders |
- | - | ||
| who bear the investment risk V. Other |
- - |
- - |
||
| A.4 | Available-for-sale financial assets | Note 8 | 697,771 | 829,700 |
| I. Equity instruments II. Debt securities |
85,099 612,672 |
125,740 703,960 |
||
| III. Investments for the benefit of life-assurance policyholders | ||||
| who bear the investment risk IV. Other |
- - |
- - |
||
| A.5 | Loans and receivables I. Debt securities |
Note 8 | 140,101 - |
130,881 - |
| II. Loans | 22,139 | 22,981 | ||
| 1. Advance payments on policies | - | - | ||
| 2. Loans to group companies and associates | Notes 8 and 15 |
22,139 | 22,981 | |
| 3. Loans to other related parties | - | - | ||
| III. Deposits with credit institutions IV. Deposits posted on accepted reinsurance |
- - |
- - |
||
| V. Receivables on direct insurance business | Note 8 | 58,524 | 53,538 | |
| 1. Policyholders | 58,524 | 53,538 | ||
| 2. Agents, brokers and intermediaries VI. Receivables on reinsurance business |
- 12,290 |
- 7,969 |
||
| VII. Receivables on coinsurance business | - | - | ||
| VIII. Payments called up | - | - | ||
| IX. Other receivables 1. Tax and social security receivable |
47,148 1,040 |
46,393 1,040 |
||
| 2. Other receivables | Notes 8 and | 46.108 | 45,353 | |
| A.6 | Held-to-maturity investments | 15 | - | - |
| A.7 | Hedging derivatives | 7,844 | - | |
| A.8 | Reinsurers' share of technical provisions | Note 10 | 19,263 | 20,153 |
| I. Provision for unearned premiums II. Life assurance provision |
4,554 - |
4,280 - |
||
| III. Provision for claims | 14,709 | 15,873 | ||
| IV. Other technical provisions | - | - | ||
| A.9 | Property, plant and equipment and investment property I. Tangible fixed assets |
Note 5 | 42,121 40,226 |
43,497 41,574 |
| II. Investment property | 1,895 | 1,923 | ||
| A.10 | Intangible assets I. Goodwill |
Note 6 | 14,467 - |
14,061 - |
| II. Economic rights arising from policy portfolios acquired from | ||||
| intermediaries | - | - | ||
| III. Other intangible assets | Notes 8 and | 14,467 | 14,061 | |
| A.11 | Holdings in group companies and associates | 15 | 69,494 | 65,785 |
| I. Holdings in associates II. Holdings in jointly controlled companies |
- - |
- - |
||
| III. Holdings in group companies | 69,494 | 65,785 | ||
| A.12 | Tax assets | Note 17 | 25,971 | 27,315 |
| I. Current tax assets II. Deferred tax assets |
2,600 23,371 |
18,896 8,419 |
||
| A.13 | Other assets | Note 7 | 104,033 | 95,777 |
| I. Assets and reimbursement rights on long-term staff remuneration | - | - | ||
| II. Prepaid fees and other acquisition costs III. Accruals |
Notes 7 and 8 | 94,608 9,425 |
87,219 8,558 |
|
| IV. Other assets | - | - | ||
| A.14 | Assets held for sale | - | - | |
| TOTAL ASSETS | 1,165,105 | 1,326,080 |
(*) Presented for comparison purposes only.
(in thousand euro)
| LIABILITIES | Notes | 2022 | 2021 (*) | |
|---|---|---|---|---|
| A.1 | Financial liabilities held for trading | - | - | |
| A.2 A.3 |
Other financial liabilities at fair value through profit or loss Debt and accounts payable |
Note 13 | - 44,677 |
- 159,871 |
| I. Subordinated liabilities | - | - | ||
| II. Deposits received from ceded reinsurance | - | - | ||
| III. Due on direct insurance business | Note 8 | 2,490 | 2,526 | |
| 1. Due to policyholders | 2,009 | 1,939 | ||
| 2. Due to agents, brokers and intermediaries 3. Conditional claims |
481 - |
587 - |
||
| IV. Due on reinsurance business | Note 8 | 1,363 | 1,244 | |
| V. Due on coinsurance business | - | - | ||
| VI. Bonds and other negotiable securities | - | - | ||
| VII. Due to credit institutions | - | - | ||
| VIII. Debts arising from activities to draw up insurance contracts IX. Other debts: |
Note 13 | - 40,824 |
- 156,101 |
|
| 1. Taxes and social security payable | 14,835 | 16,694 | ||
| 2. Due to group companies and associates | 276 | 364 | ||
| 3. Other debts | 25,713 | 139,043 | ||
| A.4 A.5 |
Hedging derivatives Technical provisions |
Note 8 Note 10 |
- 798,190 |
8,922 744,677 |
| I. Provision for unearned premiums | 470,783 | 449,740 | ||
| II. Provision for unexpired risks | 2,378 | 3,280 | ||
| III. Life assurance provision | - | - | ||
| IV. Provision for claims | 325,029 | 291,657 | ||
| V. Provision for profit sharing and premium refunds VI. Other technical provisions |
- - |
- - |
||
| A.6 | Non-technical provisions | 26,102 | 22,118 | |
| I. Provisions for taxes and other legal contingencies | - | - | ||
| II. Provision for pensions and similar obligations | - | - | ||
| III. Provisions for settlement agreements | Note 12 | 25,338 | 21,915 | |
| A.7 | IV. Other non-technical provisions Tax liabilities |
Note 17 | 764 28,006 |
203 44,456 |
| I. Current tax liabilities | - | - | ||
| II. Deferred tax liabilities | 28,006 | 44,456 | ||
| A.8 | Other liabilities | 315 | 1,109 | |
| I. Accruals II. Liabilities due to accounting mismatches |
36 - |
452 - |
||
| III. Commissions and other acquisition expenses on ceded | ||||
| reinsurance | - | - | ||
| IV. Other liabilities | 279 | 657 | ||
| A.9 | Liabilities associated with assets held for sale | - | - | |
| B. | TOTAL LIABILITIES EQUITY |
897,290 | 981,153 | |
| B.1 | Equity | Note 14 | 298,178 | 301,561 |
| I. Capital or mutual fund | 43,537 | 43,537 | ||
| 1. Subscribed capital or mutual fund | 43,537 | 43,537 | ||
| 2. (Uncalled capital) II. Share premium |
- - |
- - |
||
| III. Reserves | 244,579 | 228,820 | ||
| 1. Legal and bylaw reserves | 9,046 | 9,046 | ||
| 2. Equalisation reserve | 93,608 | 107,582 | ||
| 3. Other reserves IV. (Own shares) |
141,925 (1,018) |
112,192 (1,247) |
||
| V. Profit/(loss) carried forward | - | - | ||
| 1. Surplus | - | - | ||
| 2. (Losses carried forward) | - | - | ||
| VI. Other contributions from owners and mutual members | - | - | ||
| VII. Profit/(loss) for the year VIII. (Interim dividend and interim equalisation reserve) |
70,681 (59,601) |
108,115 (77,664) |
||
| IX. Other equity instruments | - | - | ||
| B.2 | Valuation adjustments: | Note 14 | (30,363) | 43,366 |
| I. Available-for-sale financial assets | (30,363) | 43,366 | ||
| II. Hedging arrangements | - | - | ||
| III. Foreign exchange and conversion differences IV. Correction of accounting mismatches |
- - |
- - |
||
| V. Other adjustments | - | - | ||
| B.3 | Grants, gifts and legacies received | - | - | |
| TOTAL EQUITY | 267,815 | 344,927 | ||
| TOTAL LIABILITIES AND EQUITY | 1,165,105 | 1,326,080 |
(*) Presented for comparison purposes only.
| Notes | 2022 | 2021 (*) | |||
|---|---|---|---|---|---|
| I. I.1 |
NON-LIFE INSURANCE TECHNICAL ACCOUNT Earned premiums, net of reinsurance |
900,647 | 882,728 | ||
| a) | Written premiums | ||||
| a.1) Direct Insurance a.2) Accepted reinsurance |
946,679 - |
907,189 - |
|||
| a.3) Change due to impairment of outstanding premiums | |||||
| receivable | Note 8.1.1.2 | (26) | 331 | ||
| b) | Premiums from ceded reinsurance | (26,139) | (23,392) | ||
| c) | Change in the provision for unearned premiums and unexpired risks |
- | - | ||
| c.1) Direct insurance c.2) Accepted reinsurance |
Note 10 | (20,141) - |
(1,975) - |
||
| d) | Change in the provision for unearned premiums, reinsurers' share | Note 10 | 274 | 575 | |
| I.2 | Income from property, plan and equipment and from investments | Note 8.1.2 | 68,429 | 54,402 | |
| a) | Income from investment property | 127 | 164 | ||
| b) | Income from financial investments | 34,702 | 31,918 | ||
| c) | Application of impairment adjustments for property, plant and | ||||
| equipment, and investments | |||||
| c.1) Property, plant and equipment and investment property | - | - | |||
| c.2) Financial investments Gains/(losses) on realisation of property, plant and equipment |
Note 8.1.2 | 110 | 167 | ||
| d) | and investments | ||||
| d.1) Property, plant and equipment and investment property | - | 21 | |||
| d.2) Financial investments | 33,490 | 22,131 | |||
| I.3 | Other technical income | - | - | ||
| I.4 | Claims incurred, net of reinsurance | 684,515 | 600,459 | ||
| a) | Claims and other expenses paid | ||||
| a.1) Direct Insurance a.2) Accepted reinsurance |
606,536 - |
542,962 - |
|||
| a.3) Reinsurers' Share | (14,438) | (9,960) | |||
| b) | Change in the provision for claims | ||||
| b.1) Direct Insurance | Note 10 | 33,372 | 20,116 | ||
| b.2) Accepted Reinsurance | - | - | |||
| b.3) Reinsurers' Share | Note 10 | 1,164 | (7,101) | ||
| I.5 | c) | Claims-related expenses | 57,881 - |
54,442 - |
|
| I.6 | Change in Other Technical Provisions, net of reinsurance Profit sharing and premium refunds |
637 | 594 | ||
| Claims and expenses relating to profit sharing and premium | |||||
| a) | refunds | 637 | 594 | ||
| b) | Change in the provision for profit sharing and premium refunds | - | - | ||
| I.7 | Net operating expenses | 201,412 | 202,913 | ||
| a) | Acquisition costs | 180,012 | 181,770 | ||
| b) c) |
Administration expenses Reinsurance commissions and profit participation |
25,632 (4,232) |
26,167 (5,024) |
||
| I.8 | Other technical expenses | Note 21 | (17,021) | (22,778) | |
| a) | Change in impairment due to insolvencies | - | - | ||
| b) | Change in impairment on property, plant and equipment | - | - | ||
| c) | Change in claims paid under settlement agreements | (22,750) | (24,489) | ||
| d) | Other | 5,729 | 1,711 | ||
| I.9 | Expenses from property, plant and equipment and investments Management expenses from property, plant and equipment |
31,388 | 21,896 | ||
| a) | and investments | ||||
| a.1) Expenses from property, plant and equipment and | |||||
| investment property | Note 8.1.2 | 2,062 | 1,961 | ||
| a.2) Expenses from financial investments and accounts | Note 8.1.2 | 2,991 | 4,483 | ||
| b) | Valuation adjustments for property, plant and equipment and | ||||
| investments | |||||
| b.1) Depreciation of property, plant and equipment and investment property |
28 | 28 | |||
| b.2) Impairment of property, plant and equipment and | |||||
| investment property | Note 5 | - | - | ||
| b.3) Impairment of financial investments | - | - | |||
| c) | Losses on property, plant and equipment and investments | ||||
| c.1) Property, plant and equipment and investment property | - | 7 | |||
| c.2) Financial investments | Note 5 | 26,307 | 15,417 | ||
| Profit/(loss) from the non-life technical account | 68,145 | 134,046 |
(*) Presented for comparison purposes only.
Línea Directa Aseguradora, S.A. Compañía de Seguros y Reaseguros Income statement for the years ended December 2022 and 2021. (in thousand euro)
| 2022 | 2021 (*) | |||||
|---|---|---|---|---|---|---|
| III. | NON-TECHNICAL ACCOUNT: | |||||
| III. | Profit/(loss) on the non-life technical account | 68,145 | 134,046 | |||
| III.1 | Income from property, plan and equipment and from investments | Note 8 | 16,000 | 2,500 | ||
| a) | Income from investment property | - | - | |||
| b) | Income from financial investments | 16,000 | 2,500 | |||
| c) | Application of impairment adjustments for property, plant and equipment, and investments c.1) Property, plant and equipment and investment property |
- | - | |||
| c.2) Financial investments | - | - | ||||
| III.2 | Expenses from property, plant and equipment and investments | |||||
| a) | Investment management expenses | |||||
| a.1) Expenses from financial investments and | - | - | ||||
| accounts a.2) Expenses from investments in property, plant and equipment |
- | - | ||||
| b) | Valuation adjustments for property, plant and equipment and investments |
|||||
| b.1) Depreciation of property, plant and equipment and investment property |
- | - | ||||
| b.2) Impairment of property, plant and equipment and investment property |
- | - | ||||
| b.3) Impairment of financial investments | - | - | ||||
| c) | Losses on property, plant and equipment and investments |
|||||
| c.1) Property, plant and equipment and investment property |
- | - | ||||
| c.2) Financial investments | - | - | ||||
| III.3 | Other income | Note 21 | 4,231 | 5,541 | ||
| a) | Income from pension fund management activity | |||||
| b) | Other income | 4,231 | 5,541 | |||
| III.4 | Other expenses | Note 21 | 43 | 390 | ||
| a) | Expenses from pension fund management activity | |||||
| b) | Other expenses | 43 | 390 | |||
| III.5 | Subtotal (Profit/(loss) on the non-Technical Account) | 20,188 | 7,651 | |||
| III.6 | Profit/(loss) before tax | 88,333 | 141,697 | |||
| III.7 | Income tax Note 17 Profit/(loss) for the year |
17,652 | 33,582 | |||
| III.8 | 70,681 | 108,115 |
(*) Presented for comparison purposes only.
| STATEMENT OF RECOGNISED INCOME AND EXPENSE | 2022 | 2021 (*) | |
|---|---|---|---|
| I) PROFIT OR LOSS FOR THE PERIOD | Note 3 | 70,681 | 108,115 |
| II) OTHER RECOGNISED INCOME AND EXPENSE | (73,729) | (1,031) | |
| II.1. Available-for-sale financial assets | Note 8 | (98,305) | (1,375) |
| Gains/(losses) on valuation adjustments | (87,354) | 5,191 | |
| Amounts transferred to the statement of profit or loss | (10,951) | (6,566) | |
| Other reclassifications | - | - | |
| II.2. Cash flow hedges | - | - | |
| Gains/(losses) on valuation adjustments | - | - | |
| Amounts transferred to the statement of profit or loss | - | - | |
| Amounts transferred to the initial value of the hedged items | - | - | |
| Other reclassifications | - | - | |
| III.3. Hedging of net investments in foreign operations | - | - | |
| Gains/(losses) on valuation adjustments | - | - | |
| Amounts transferred to the statement of profit or loss | - | - | |
| Other reclassifications | - | - | |
| II.4. Foreign exchange and conversion differences | - | - | |
| Gains/(losses) on valuation adjustments | - | - | |
| Amounts transferred to the statement of profit or loss | - | - | |
| Other reclassifications | - | - | |
| II.5. Correction of accounting mismatches | - | - | |
| Gains/(losses) on valuation adjustments | - | - | |
| Amounts transferred to the statement of profit or loss | - | - | |
| Other reclassifications | - | - | |
| II.6. Assets held for sale | - | - | |
| Gains/(losses) on valuation adjustments | - | - | |
| Amounts transferred to the statement of profit or loss | - | - | |
| Other reclassifications | |||
| II.7. Actuarial Gains/(losses) on long-term staff remuneration | - | - | |
| II.8. Other recognised income and expense | - | - | |
| II.9. Income tax | 24,576 | 344 | |
| III) TOTAL RECOGNISED INCOME AND EXPENSE | (3,048) | 107,084 |
(*) Presented for comparison purposes only.
(in thousand euro)
| Share capital capital |
Reserves | Treasury shares |
Profit/(loss) for the year |
Interim dividend and interim equalisation reserve |
Valuation adjustments |
Total | |
|---|---|---|---|---|---|---|---|
| E. BALANCE AT END OF 2020 (*) |
37,512 | 228,183 | - | 132,671 | (6,964) | 44,397 | 435,799 |
| D. ADJUSTED BALANCE AT BEGINNING OF 2021 (*) |
37,512 | 228,183 | - | 132,671 | (6,964) | 44,397 | 435,799 |
| I. Total recognised income and expense (Note 8) | - | - | - | 108,115 | - | (1,031) | 107,084 |
| II. Transactions with owners or mutual members | 6,025 | (126,025) | (1,247) | - | (77,664) | - | (198,911) |
| 1. Capital increases or mutual fund (Note 14) | 6,025 | (6,025) | - | - | - | - | - |
| 2. ( - ) Capital reductions or mutual funds |
- | - | - | - | - | - | - |
| 3. Conversion of financial liabilities into equity | - | - | - | - | - | - | - |
| 4. ( - ) Distribution of dividends or payments due to mutual members (Notes 3 and 8) |
- | (120,000) | - | - | (77,644) | - | (197,664) |
| 5. Transactions with own shares or holdings (net) (Notes 14 and 22) | - | - | (1,247) | - | - | - | (1,247) |
| 6. Increase (decrease) in equity resulting from a business combination | - | - | - | - | - | - | - |
| 7. Other transactions with owners or mutual members | - | - | - | - | - | - | - |
| III. Other changes in equity | - | 126,663 | - | (132,671) | 6,964 | - | 956 |
| 1. Payments based on equity instruments | - | 955 | - | - | - | - | 955 |
| 2. Transfers between equity items | - | 125,707 | - | (132,671) | 6,964 | - | - |
| 3. Other changes | - | - | - | - | - | - | - |
| E. BALANCE AT END OF 2021 (*) |
43,537 | 228,820 | (1,247) | 108,115 | (77,664) | 43,366 | 344,927 |
| D. ADJUSTED BALANCE AT BEGINNING OF 2022 | 43,537 | 228,820 | (1,247) | 108,115 | (77,664) | 43,366 | 344,927 |
|---|---|---|---|---|---|---|---|
| I. Total recognised income and expense (Note 8) | - | - | - | 70,681 | - | (73,729) | (3,048) |
| II. Transactions with owners or mutual members | - | - | 229 | (21,459) | (52,480) | - | (73,710) |
| 1. Capital increases or mutual fund (Note 14) | - | - | - | - | - | - | - |
| 2. ( - ) Capital reductions or mutual funds |
- | - | - | - | - | - | - |
| 3. Conversion of financial liabilities into equity | - | - | - | - | - | - | - |
| 4. ( - ) Distribution of dividends or payments due to mutual members (Notes 3 and 8) |
- | - | - | (21,459) | (52,480) | - | (73,939) |
| 5. Transactions with own shares or holdings (net) (Notes 14 and 22) | - | - | 229 | - | - | - | 229 |
| 6. Increase (decrease) in equity resulting from a business combination | - | - | - | - | - | - | - |
| 7. Other transactions with owners or mutual members | - | - | - | - | - | - | - |
| III. Other changes in equity (Note 14) | - | 15,759 | - | (86,656) | 70,543 | - | (354) |
| 1. Payments based on equity instruments | - | (354) | - | - | - | - | (354) |
| 2. Transfers between equity items | - | 8,992 | - | (86,656) | 77,664 | - | - |
| 3. Other changes | - | 7,121 | - | - | (7,121) | - | - |
| E. BALANCE AT END OF 2022 | 43,537 | 244,579 | (1,018) | 70,681 | (59,601) | (30,363) | 267,815 |
(*) Presented for comparison purposes only.
| 2022 | 2021(*) | ||
|---|---|---|---|
| A) | CASH FLOWS FROM/(USED IN) OPERATING ACTIVITIES | ||
| A.1 | Insurance activities | ||
| 1. Proceeds from premiums on direct insurance, coinsurance and accepted reinsurance |
941,667 | 908,396 | |
| 2. Payments for direct insurance, coinsurance and accepted reinsurance | 635,284 | 576,145 | |
| 3. Proceeds from ceded reinsurance | 5,301 | 769 | |
| 4. Payments for ceded reinsurance | 16,973 | 11,797 | |
| 5. Reimbursements of claims | 31,078 | 31,816 | |
| 6.- Payments for intermediaries | 16,855 | 20,041 | |
| 7.- Other proceeds from operating activities | - | - | |
| 8.- Other payments for operating activities | 249,252 | 237,005 | |
| 9.- Total proceeds from insurance activities (1+3+5+7) = I | 978,046 | 940,981 | |
| A.2 | 10.- Total payments for insurance activities (2+4+6+8) = II Other operating activities |
918,364 | 844,988 |
| 3.- Proceeds from other operating activities | 5,541 | 7,000 | |
| 4.- Payments for other operating activities | 1,025 | 610 | |
| 5.- Total proceeds from other operating activities (1+3) = III | 5,541 | 7,000 | |
| 6.- Total payments for other operating activities (2+4) = IV | 1,025 | 610 | |
| 7.- Income tax collected/(paid) (V) | 7,789 | (20,226) | |
| Total net cash flows from operating activities (I-II+III-IV + - V) | 71,987 | 82,157 | |
| A.3 B) |
CASH FLOWS FROM/(USED IN) INVESTING ACTIVITIES | ||
| B.1) | Proceeds from investing activities | ||
| 1.- Property, plant and equipment 2.- Investment property |
- 127 |
- 164 |
|
| 3.- Intangible assets | - | - | |
| 4.- Financial instruments | 287,666 | 192,412 | |
| 5.- Holdings in group, jointly controlled and associate companies | - | 700 | |
| 6.- Interest received | 24,880 | 27,203 | |
| 7.- Dividends collected | 18,871 | 4,724 | |
| 8.- Business unit | - | - | |
| 9.- Other proceeds from investing activities | - | - | |
| 10.- Total proceeds from investing activities (1+2+3+4+5+6+7+8+9) = VI | 331,544 | 225,203 | |
| B.2) | Payments for investing activities 1.- Property, plant and equipment |
1,803 | 3,138 |
| 2.- Investment property | - | - | |
| 3.- Intangible assets | 4,838 | 6,204 | |
| 4.- Financial instruments | 258,487 | 129,926 | |
| 5.- Holdings in group, jointly controlled and associate companies | 3,600 | 7,000 | |
| 6.- Business unit | - | - | |
| 7.- Other payments for investing activities | 4,068 | 4,342 | |
| 8.- Total payments for investing activities (1+2+3+4+5+6+7) = VII | 272,796 | 150,610 | |
| B.3) | Total net cash flows from investing activities (VI - VII) | 58,748 | 74,593 |
| C) C.1) |
CASH FLOWS FROM/(USED IN) FINANCING ACTIVITIES Proceeds from financing activities |
||
| 1. Subordinated liabilities | - | - | |
| 2. Proceeds from the issuance of equity instruments and capital increase | - | - | |
| 3.- Payments due to mutual members and contributions from owners or | |||
| mutual members | - | - | |
| 4. Disposal of own shares | 257 | - | |
| 5. Other proceeds from financing activities | 30,651 | 4,047 | |
| C.2) | 6. Total proceeds from financing activities (1+2+3+4+5) = VIII Payments for financing activities |
30,908 | 4,047 |
| 1. Dividends to shareholders | 73,940 | 197,664 | |
| 2. Interest paid | - | - | |
| 3. Subordinated liabilities | - | - | |
| 4. Payments on return of contributions to shareholders | - | - | |
| 5. Supplementary members' calls and return of contributions to mutual | - | - | |
| members 6. Acquisition of own shares |
384 | 1,247 | |
| 7. Other payments for financing activities | 145,957 | 4,472 | |
| 8. Total payments for financing activities (1+2+3+4+5+6+7) = IX | 220,281 | 203,383 | |
| C.3) | Total net cash flows from/(used in) financing activities (VIII - IX) | (189,373) | (199,336) |
| Effects of exchange rate changes (X) | 3,767 | (149) | |
| Total increase/(decrease) in cash and cash equivalents (A.3 + B.3 + C.3 + - X) | (54,871) | (42,735) | |
| Cash and cash equivalents at beginning of year | 98,911 | 141,646 | |
| Cash and cash equivalents at end of year | 44,040 | 98,911 | |
| Components of cash and cash equivalents at end of year | |||
| 1. Cash and banks 2. Other financial assets |
28,062 15,978 |
98,911 - |
|
| Total cash and cash equivalents at end of year (1 + 2 - 3) | 44,040 | 98,911 |
(*) Presented for comparison purposes only.
The Company was incorporated in Madrid, on 13 April 1994, under the name "Bankinter Seguros Directos, S.A. Compañía de Seguros y Reaseguros". On 6 July 1994, it changed its name to "Bankinter Aseguradora Directa, S.A. Compañía de Seguros y Reaseguros". The decision was reached at the General Shareholders' Meeting held on 26 January 1995 to change its name to "Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros" (hereinafter, "the Company" or "Línea Directa").
The Company engages in insurance and reinsurance activities in the motor, home, other insurance and other non-life segments, all of which it is authorised to carry out by the Spanish Directorate General of Insurance and Pension Funds. On 19 July 2017, the Directorate granted authorisation to operate also within the medical assistance line of the wider healthcare segment. Línea Directa began marketing and selling health insurance in October 2017.
Its registered office is located at calle Isaac Newton, 7, in the municipality of Tres Cantos (Madrid). The Company operates entirely in Spain and Portugal.
With respect to Portugal, the Group was authorised to operate in the Assistance segment on 25 September 2017. As this line of activity was residual and immaterial in both 2022 and 2021, it has not been deemed relevant to break down the information by geographical area. Its business distribution channels are mainly telephone and internet sales.
The Parent's shares have been listed and traded on the continuous market of the Madrid Stock Exchange since 29 April 2021. Bankinter, S.A. holds a 17.4% stake in the Parent, while the remaining 82.6% was distributed among its shareholders by delivering one share in Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros for each Bankinter share held (Note 14).
These annual accounts have been drawn up by the directors in accordance with the regulatory financial reporting framework applicable to the Company, as set out in:
when referring to the Regulations), as enacted by Law 20/2015 and Royal Decree 1060/2015, respectively.
The accompanying annual accounts have been prepared from the Company's accounting records and are presented in accordance with the applicable financial reporting framework, especially the accounting principles and criteria contained therein, to provide a true and fair view of the Company's equity, financial position, operating results and cash flows for the year.
These annual accounts, which were authorised for issue by the Company's directors at the meeting held on 23 February 2023, will be submitted for approval by shareholders at their Annual General Meeting and are expected to be approved without any changes made. The Group's financial statements for 2021 were approved at the Annual General Meeting held on 24 March 2022.
As the Company is the parent of the Línea Directa Aseguradora Group, the Company's Board of Directors has also drawn up, together with these annual accounts, the consolidated annual accounts for 2022 of the Línea Directa Aseguradora Group. The effect of applying consolidation criteria in relation to the accompanying separate financial statements for that year is an increase in assets and equity at year-end 2022 of € 30,310 thousand and € 22,685 thousand (€ 42,398 thousand and € 33,347 thousand in 2021) and an increase in profit for 2021 of € 2,021 thousand (€ 2,021 thousand in 2021).
The subsidiaries at which the Company holds a direct stake and that are included in the scope of consolidation are as follows:
| Subsidiaries (see Note 8.1.1.3) |
Registered office |
Activity | Stake |
|---|---|---|---|
| Línea Directa Asistencia, S.L.U. |
Ochandiano 12, 28023, Madrid |
Vehicle inspections and roadside assistance |
100% |
| Moto Club LDA, S.L.U. | Isaac Newton 7, 28760, Tres Cantos |
Sundry services related to motorcycles |
100% |
| Centro Avanzado de Reparaciones CAR, S.L.U. |
Avenida del Sol, 9, 28850, Torrejón de Ardoz |
Provision of vehicle repair services |
100% |
| Ambar Medline, S.L.U. | Ronda de Europa 7, 28760, Tres Cantos |
Insurance brokerage |
100% |
| LDActivos, S.L.U. | Ronda de Europa 7, 28760, Madrid |
Asset management on behalf of insurance companies |
100% |
| LDA Reparaciones, S.L.U. |
Ronda de Europa 7, 28760, Tres Cantos |
Claims management, claims-related repair work and other specialised household services. |
100% |
Investments in subsidiaries are recognised at cost of acquisition or issue, less any accumulated impairment losses.
When drawing up the annual accounts, the Company's directors must make certain forward-looking estimates and judgements that are continuously assessed and based on past experience and other factors, including expectations as to future events that are believed to be reasonably likely given the current circumstances.
While these estimates have been made on the basis of the best information available in relation to the events analysed at the balance sheet date, it is possible that future events may require these estimates to be modified (upwards or downwards) in subsequent years. Any resulting changes would be reflected in the corresponding statements of profit or loss.
The main estimates made by the Company's directors are as follows.
Assets and liabilities relating to insurance contracts are recognised in accordance with the accounting policies set out in Note 4.g) to these Notes. The Company also makes judgments and estimates approved by the Directorate-General for Insurance to calculate the technical provisions for the motor insurance segments. Statistical methods are used to determine these provisions. For the other lines of business in which the Company operates, an estimate is made on a case-by-case basis for non-life insurance technical provisions.
On 29 December 2021, the Directorate-General for Insurance and Pension Funds sent a resolution of the application file for a change in the statistical methodology used in the automotive sector, in which it authorises Línea Directa Aseguradora to calculate the technical provisions of benefits in the motor sector using the Merz & Wüthrich stochastic methodology, and the deterministic methodology of average cost as a contrast methodology. The methodological change was first applied at the end of 2021 and did not have a significant impact.
Under current legislation, taxes cannot be considered definitively settled until the duly submitted returns have been inspected by the tax authorities, or until the four-year limitation period has lapsed. In the opinion of the Company's directors, there are no contingencies that might result in any further significant liabilities for the Company.
The Company analyses annually whether there are any indications of impairment on its assets, which are tested for impairment if and when any such indications exist.
The useful life of these assets has been calculated on the basis of the best estimate of the Company's directors for the period over which they will produce income, taking into account the depreciation actually incurred from their operation, use and enjoyment.
To determine the fair value of financial instruments when there is no price in an active market, the Company's directors request the price of the instrument from the depositary.
The Company's annual accounts have been drawn up in accordance with the generally accepted accounting principles set out in Royal Decree 1317/2008 of 24 July and subsequent amendments, which enacted the Accounting Plan for Insurance Companies.
All mandatory accounting principle with a significant impact on the financial statements have been duly applied.
The figures for 2021 included in these Notes are presented for comparison purposes only.
Certain items in the balance sheet, statement of profit or loss, statement of changes in equity and statement of cash flows are presented together for easier understanding. However, disaggregated information has been included in the relevant notes to the financial statements where such information is deemed significant.
The process of drawing up these annual accounts did not reveal any material errors that would have led to the restatement of the amounts included in the annual accounts for 2021.
There were no significant changes in accounting criteria in 2022 when compared to those applied in 2021.
Financial income and expenses arising from investments related to insurance activity are recognised in the technical account for the non-life insurance business. All other income and expenses are recorded in the non-technical account.
Other income and expenses are distributed accordingly on the basis of net premiums written, except expenses attributable to claims, which are recognised on the basis of the provision for claims.
The proposed distribution of earnings for 2022, which the Company's Board of Directors will lay before the General Shareholders' Meeting for approval, is as follows:
| Thousand euro | |||
|---|---|---|---|
| 2022 | 2021 | ||
| Distribution basis (Profit) | 70,681 | 108,115 | |
| Distributed: | |||
| To interim dividends (Note 14.c) | 52,481 | 77,664 | |
| To the interim equalisation reserve (Note 14.c) | 7,121 | - | |
| To the voluntary reserve | 11,080 | 8,992 | |
| A Final dividend | 1,090 | 21,459 |
Below is a breakdown of the liquidity statements of each interim dividend for 2022 and 2021:
| Resolution of | ||||
|---|---|---|---|---|
| 21.04.2022 | 20.09.2022 | 13.12.2022 | ||
| Net profit at date of resolution | 24,189 | 48,976 | 58,312 | |
| Less: | ||||
| Other reserves | - | - | - | |
| Dividends paid | - | (21,770) | (44,079) | |
| Unrestricted profit | 24,189 | 27,206 | 14,223 | |
| Proposal to pay interim dividends | 21,770 | 22,309 | 8,402 | |
| Total dividend to be paid | 21,770 | 22,309 | 8,402 | |
| Cash liquidity prior to payment | 108,217 | 178,141 | 20,782 | |
| Expected receipts less expected | ||||
| payments | 18,514 | (28,743) | 577 | |
| Remaining cash | 126,731 | 149,398 | 21,359 |
| Resolution of | |||||
|---|---|---|---|---|---|
| 29.06.2021 | 23.09.2021 | 13.12.2021 | |||
| Net profit at date of resolution | 29,596 | 58,211 | 86,293 | ||
| Less: | |||||
| Other reserves | (1,634) | - | - | ||
| Unrestricted profit | 27,962 | 58,211 | 86,293 | ||
| Proposal to pay interim dividends | 26,636 | 25,754 | 25,274 | ||
| Total dividend to be paid | 26,636 | 25,754 | 25,274 | ||
| Cash liquidity prior to payment | 61,410 | 84,669 | 144,460 | ||
| Expected receipts less expected payments |
63,888 | (17,561) | (12,634) | ||
| Remaining cash | 125,298 | 67,108 | 131,826 |
The measurement standards relied on when drawing up the accompanying annual accounts are described below:
Intangible assets are recognised at acquisition expense or, where applicable, at production cost, less the corresponding amortisation.
Includes amounts paid for ownership of, or the right to use software where the term of the arrangement exceeds one year. These assets are amortised on a straight-line basis over a period of four years.
For the purposes of impairment, the Company assesses whether there is any indication of impairment at least once a year if the asset's carrying amount exceeds its recoverable amount. If so, the carrying amount is immediately lowered to match the recoverable amount.
The Society recognises the derecognition of an intangible asset on disposal or when it does not expect to receive future economic benefits from its use or disposal. The date of disposal of an intangible asset is the date on which the buyer acquires control of the asset.
Land, natural assets and buildings that are held to obtain income, capital gains or both qualify as real estate investments. Land, natural assets and buildings held for the provision of services or for administrative purposes for own use are treated as property, plant and equipment.
Property, plant and equipment and investment property are recognised at their acquisition price, which includes, in addition to the purchase price, all additional expenses incurred, including finance expenses, until the asset is put into operation.
Asset expansion and improvement costs are added to assets as an increase in the value of the asset only when they result in an increase in its capacity, floor area, or return, or when they lengthen its useful life, whereupon the carrying amount of the replaced items replaced is derecognised. Under no circumstances does repair and maintenance work qualify as improvements.
These assets are depreciated systematically on a straight-line basis over their estimated useful life, taking into account the depreciation effectively sustained as a result of their operation, use and enjoyment. The following depreciation rates are used to calculate depreciation:
| Property, plant and equipment and investment property |
Rate |
|---|---|
| Furniture and installations | 4 – 12% |
| IT equipment | 10 - 25% |
| Other property, plant and equipment | 12 - 15% |
| Buildings | 2% |
At year-end, any relevant valuation adjustments are made to property, plant and equipment. For the purposes of impairment, the Company assesses whether there is any indication of impairment at least once a year if the asset's carrying amount exceeds its recoverable amount. If so, the carrying amount is immediately lowered to match the recoverable amount.
Recoverable amount is the higher of fair value less costs to sell and value in use. For property assets, fair value is equal to the appraisal value determined by a valuation company authorised to value property within the mortgage market, in accordance with Order ECO/805/2003 of 27 March, regulating the valuation of property assets and specific rights for certain financial purposes.
Value in use is the present value of expected future cash flows through use and, as the case may be, disposal of the asset in the normal course of business.
Order ECC 371/2013 of 4 March requires insurance companies to instruct an appraisal company to review the valuations of their property assets once two years have elapsed from the previous valuation.
Recoverable amount must be determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets. If this is the case, the recoverable amount is determined for the cash-generating unit (CGU) to which it belongs.
Losses related to the impairment of the CGU initially reduce, where applicable, the value of the goodwill allocated to the CGU and subsequently to the other assets of the CGU, pro rata on the basis of the carrying amount of each asset, subject to the limit for each asset of the higher of its fair value less costs of disposal, its value in use and zero.
At each reporting date, the Company assesses whether there is any indication that the impairment loss recognised in prior periods no longer exists or may have decreased. Impairment losses are reversed only if there has been a change in the estimates used to determine the asset's recoverable amount. The reversal of the impairment loss is credited to profit or loss.
However, the reversal of the loss cannot have the effect of increasing the carrying amount of the asset above the carrying amount it would have had, net of depreciation, had the impairment not been recognised.
The amount of the reversal of the impairment loss of a CGU is allocated to the assets of the CGU pro rata on the basis of the carrying amount of the assets, with the limit per asset being the lower of its recoverable amount and the carrying amount it would have had, net of depreciation, had the loss not been recognised.
Acquisition expenses, included on the assets side of the consolidated balance sheet, are deferred subject to the limit established in the technical notes for each product and/or segment and the maturity of the policies.
Note 8 to these statements shows financial assets at 31 December 2022, by type and classified in accordance with the following criteria:
This heading comprises cash in hand, bank current accounts, deposits and reverse repurchase agreements that meet all the following criteria:
For the purposes of the statement of cash flows, occasional overdrafts that form part of the Company's cash management process are deducted from cash and cash equivalents.
Non-derivative financial assets with fixed or determinable payments that are not quoted on an active market, such as bank deposits and outstanding insurance premiums. This category also includes receivables from third parties on reinsurance operations, as well as from intermediaries and policyholders, with the appropriate impairment allowances posted where applicable.
These financial assets are initially measured at fair value, including directly attributable transaction costs, and subsequently at amortised cost. Accrued interest is recognised at the effective interest rate, which is defined as the discount rate that exactly discounts the carrying amount of the instrument to its total estimated cash flows through to maturity. However, trade receivables with a maturity of up to one year are measured, both on initial recognition and subsequently, at nominal value where the effect of not discounting the flows is not material.
At least at year end, the necessary valuation adjustments for impairment are made if there is objective evidence that not all the amounts owed will be recovered.
The amount of the impairment loss is the difference between the asset's carrying amount and the present value of estimated future cash flows, discounted at the effective interest rate at the time of initial recognition. Value adjustments, and any reversal thereof, are recognised in the statement of profit or loss. Reversal of impairment is limited to the carrying amount of the credit recognised at the date of the reversal had no such impairment been recorded.
In particular, impairment of outstanding premiums is calculated on the part of the tariff premiums accrued in the financial year net of the loading for contingencies which, foreseeably and in accordance with lessons learned from previous years, is not going to be collected. This will depend on the age of the premiums and, as the case may be, the current status of the claim before the courts. Note that certain premium receipts may require special treatment due to their unique characteristics or features.
If, in a subsequent period, the amount of the impairment loss decreases and the reduction can be objectively attributed to an event occurring after the impairment was recognised (such as an improvement in the debtor's credit quality), the reversal of the previously recognised impairment is recognised in the separate statement of profit or loss.
Receivables from claim recoveries are capitalised when their realisation is sufficiently guaranteed, that is, once the other insurer acknowledges that its policyholder is at fault and therefore acknowledges its debt with the Company. The amount is recognised at nominal value.
The Company uses this category to show investments in the equity of group, jointly controlled and associate companies, as such terms are defined under current law and regulations.
They are initially measured at cost, which is equivalent to the fair value of the consideration delivered plus transaction costs. The initial measurement includes the amount of any pre-emptive subscription rights that may have been acquired.
Fees paid to legal advisors or other professionals in relation to the acquisition of investments in the assets of group companies that confer control over those companies are charged directly to the statement of profit or loss.
Following the initial measurement, they are measured at cost less any accumulated impairment losses. However, when there is an investment prior to its classification as a group, jointly controlled or associate company, the cost of the investment is treated as its carrying amount before acquiring that classification. Valuation adjustments previously recognised directly in equity remain there until they are derecognised.
If there is objective evidence that the carrying amount is not recoverable, the appropriate valuation adjustments are made for the difference between the carrying amount and the recoverable amount, the latter being the higher of fair value less costs to sell and the present value of the cash flows from the investment. Unless there is better evidence of the recoverable amount, the process of estimating the impairment of these investments is based on the equity of the investee, adjusted by any unrealised gains existing at the measurement date. The value adjustment and, as the case may be, its reversal are recorded in the statement of profit or loss for the year in which they occur. Reversal of impairment is limited to the carrying amount of the investment that would have been recognised at the date of reversal had no impairment been recorded.
The Company uses this heading to recognise debt securities, swaps of certain or predetermined flows and equity instruments that are not classified in any of the above categories, nor as assets held for trading, other assets at fair value through profit or loss, or loans or receivables.
They are measured at fair value, which, unless there is evidence to the contrary, will be the transaction price. Changes are recognised directly in equity until the asset is sold or impaired, whereupon the cumulative gains and losses in equity are taken to the statement of profit or loss, provided that it is possible to determine their fair value. Gains and losses resulting from exchange rate differences on monetary financial assets denominated in foreign currency are recognised in the statement of profit or loss.
At each balance sheet date, the Company assesses whether there is objective evidence that a financial asset or a group of financial assets is impaired, considering those situations that generate such evidence, whether individually or in combination with others. The Group considers evidence of possible impairment to be a significant or prolonged decline in the market value of equity or fixed income securities, individually considered, to below their cost or amortised cost.
When there is a significant or prolonged decline in the fair value of an available-for-sale financial asset, the cumulative loss previously recognised in equity is removed from equity and recognised in the statement of profit or loss for the year, even if the financial asset has not been derecognised. Impairment losses recognised in profit or loss for an investment in an equity instrument classified as available for sale are not reversed through profit or loss for the year. Meanwhile, reversals associated with debt instruments are recognised in the statement of profit or loss. Reversal of impairment is limited to the carrying amount of the investment that would have been recognised at the date of reversal had no impairment been recorded.
In the case of debt securities, value adjustments are made if there is objective evidence that their value has deteriorated as a result of a reduction or delay in the estimated future cash flows, which may be down to the debtor's insolvency.
For investments in equity instruments, the non-recoverability of the asset's carrying amount, evidenced by, for example, a prolonged or significant decline in its fair value, will warrant a value adjustment. On this point, there is a presumption that impairment exists (on a permanent basis) if there has been a decline of more than 40% in the listed value of the asset, or if there has been a prolonged decline in the value of the asset over a period of one and a half years without seeing any recovery in its value. Valuation allowance is the difference between cost or amortised cost less, where applicable, any valuation allowances previously recognised in the statement of profit or loss and the fair value at time of valuation.
For equity instruments measured at cost because their fair value cannot be determined, value adjustments are made for the difference between their carrying amount and recoverable amount, the latter being the higher of fair value less costs to sell and the present value of the cash flows deriving from the investment. Unless there is better evidence of the recoverable amount, the process of estimating the impairment of these investments is based on the equity of the investee, adjusted by any unrealised gains existing at the measurement date.
Value adjustments and, as the case may be, their reversal, are recognised in the statement of profit or loss for the year in which they occur, except for equity instruments, the reversal of which is recorded against equity. Reversal of impairment is limited to the carrying amount of the investment that would have been recognised at the date of reversal had no impairment been recorded.
The fair value of a financial instrument on a given date means the amount for which it could be bought or sold between knowledgeable, willing buyers and sellers on an arm's length basis. The fair values of listed investments are based on current purchase prices. If the market for a financial asset is not active (and for unlisted securities), the Company determines fair value by reference to other substantially similar instruments and estimated future cash flow discounting methods. The Company may use these models directly or the counterparty who acted as seller may do so.
Financial assets are derecognised when all the risks and rewards of ownership of the asset have been substantially transferred. In the specific case of accounts receivable, this is generally understood to occur if and when the risks of insolvency and default have been transferred.
Conversely, the Group does not derecognise financial assets, and recognises a financial liability for an amount equal to the consideration received, on transfers of financial assets in which substantially all the risks and rewards of ownership are retained.
Derecognition of a financial asset entails the recognition, in the statement of profit or loss, of the difference between the carrying amount of the financial asset and the consideration received, including attributable transaction costs. Any liabilities transferred other than the cash or asset assumed are also recognised.
Dividend income is recognised as income in the statement of profit or loss when the right to receive payment is established.
Financial instruments are valued by taking their price in an active market or, failing that, by applying suitable valuation models and techniques.
An active market is one in which the following conditions exist simultaneously:
There is no need for the market to be regulated, though it must be transparent and deep. Therefore, prices that are known and readily accessible to the public from financial information providers, and that reflect actual, current and regularly occurring market transactions will be considered as valid prices in an active market.
If no price can be found in an active market, the price must be estimated instead through a valuation model or technique, consistent with the accepted methodology used in the market for pricing, while maximising the use of observable market data. For debt instruments, the method of discounting certain or likely flows at a discount rate for credit risk and liquidity risk adjusted to market conditions may be used.
The Group classifies its financial liabilities according to the purpose for which they were acquired. Management determines the classification of its financial liabilities at initial recognition.
The Company uses this heading to show both trade and non-trade payables.
These debts are initially recognised at fair value adjusted for directly attributable transaction costs, and are subsequently recognised at amortised cost using the effective interest method. The effective interest rate is the discount rate that exactly discounts the carrying value of the instrument to the expected flow of future payments through to maturity of the liability.
However, trade payables with a maturity not exceeding one year and that do not have a contractual interest rate are measured, both initially and subsequently, at their nominal value when the effect of not discounting the cash flows is immaterial.
If existing debts are renegotiated, no substantial change to the financial liability will be deemed to exist when the present value of the cash flows of the new liability, including net fees, does not differ significantly from the present value of the outstanding cash flows under the original liability, both discounted at the effective interest rate of the latter.
The Company derecognises a financial liability or part of one when it has discharged the underlying obligation or is otherwise legally released from the underlying responsibility, whether by virtue of a court ruling or by the creditor itself.
Derecognition of a financial liability entails the recognition, in the statement of profit or loss, of the difference between the carrying amount of the financial liability and the consideration paid, including attributable transaction costs. Any assets transferred other than the cash or liability assumed are also recognised.
Hedging derivatives are recognised under "Hedging derivatives" on the assets or liabilities side of the balance sheet, as appropriate.
Hedging derivatives are derivatives whose fair value or future cash flows are intended to offset changes in the fair value or future cash flows of hedged items.
Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in the statement of profit or loss, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.
Interest rate hedging cover exposure to changes in interest flows attributable to a specific risk associated with interest rate fluctuations. The Company did not designate any such hedges in 2022 or 2021.
In relation to derivatives held by the Group that are classified as fair value hedges, the following steps are taken to measure the effectiveness of the hedge:
Firstly, the Company has made a synthetic bond equivalent to payment of a fixed coupon plus the collection of the variable rate (in the Company's case, Euribor 6m + spread). The standard Euribor 6m curve has been used for discounting flows. The present value of the future flows is then calculated. The final step is to confirm that the difference between both current values falls within the parameters marked as effective hedging (80% - 125%).
Corporate income tax expense is the amount accruing in the year for that tax, comprising both current and deferred tax expense.
Both current and deferred tax expense are recognised in the statement of profit or loss. However, the tax effect related to items that are recorded directly in equity is recognised in equity.
Current tax assets and liabilities are measured at the amounts expected to be paid to, or recovered from, the tax authorities in accordance with prevailing legislation or approved and pending publication at year-end.
Deferred taxes are calculated, using the liability method, on the temporary differences arising between the tax bases of the assets and liabilities and their carrying amounts. Deferred tax is determined by applying the tax regulations and rates approved or about to be approved at the balance sheet date and that are expected to apply when the corresponding deferred tax asset is realised or the deferred tax liability is settled.
Deferred tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised. Deferred tax is recognised on temporary differences arising on investments in subsidiaries, associates and joint ventures, except where the Company is able to control the timing of the reversal of the temporary differences and it is probable that the reversal will not occur in the foreseeable future.
This represents the fraction of premiums written in the period that is recognised in the period between the reporting date and the end of the policy's coverage period on a policy-to-policy basis and using the premium prices accrued during the period as the basis for calculation, net of the loading for contingencies. The accrual of the annual premium for the calculation of the provision for unearned premiums is calculated on a straight-line basis.
This complements the provision for unearned premiums where the amount of the latter is not enough to cover the amount of all risks and expenses to be covered during the period of coverage not elapsed since the year end. When calculating this provision, the guarantees are grouped by product and the reference periods of two and four years set out in Article 31 of the ROSSP are applied to the respective segments or commercial products.
The provision for claims represents the total amount of the insurance company's outstanding obligations arising from claims to have occurred prior to the reporting date.
The Company recognises this provision for an amount that enables it to cover the cost of the claims; i.e. an amount sufficient to cover all external expenses, including late-payment interest and any penalties provided for at law, and internal expenses in managing and processing claims, irrespective of their origin, occurring up until the full settlement and payment of the claims, less any amounts already paid.
The provision for claims in turn comprises the following provisions: the provision for claims pending settlement or payment and for claims not reported, and the provision for internal claims settlement costs.
On 18 January 2008, the Group was authorised by the Directorate-General for Insurance and Pension Funds to apply a statistical approach in calculating the technical provision for claims in the motor segment, in accordance with Additional Provision 18 of Law 20/2015, of 14 July.
On December 29, 2021, the General Directorate of Insurance and Pension Funds sent a resolution of the application file for a change in the statistical methodology used in the automotive sector, in which it authorizes Línea Directa Aseguradora to calculate the technical provisions of benefits in the motor sector using the Merz & Wüthrich stochastic methodology and as a contrast methodology the deterministic methodology of average cost. The methodological change began to be applied at the end of 2021 and did not have a significant impact.
In the provision for benefits in the Home, Assistance and Health segments, for the provision for claims pending settlement or payment, estimates have been made on the basis of an individual analysis of each case file (based on the best information available at year-end). The calculation process is in accordance with the provisions of the Regulation on the Organisation and Supervision of Private Insurance. For the provision of claims pending declaration, the calculation was made according to the formula established by the Regulations on the Administration and Supervision of Private Insurance.
A sufficient amount is posted to the provision to cover internal expenses from claim settlements so as to cover the expenses needed for the resolution of all claims outstanding at the close of the financial year. It is calculated in accordance with the Regulation on the Organisation and Supervision of Private Insurance.
This reserve, unlike those mentioned above, is recognised in the Company's equity and is not available for distribution. Once a year, the Company shall determine the amount by which this reserve for the Motor Third Party Liability segment should be increased, taking into account the security surcharge included in the tariff premiums for certain insurance contracts, as well as the other provisions laid down in the Regulation, which shall be charged to the distribution of profits for the financial year. Once this distribution of earnings has been approved at the General Shareholders' Meeting, the amount is taken to equity. This reserve can only be used to offset deviations in the loss ratio for retained insurance activities. If the Company reports losses in the year, it reports the amount of the equalisation reserve, which, together with the debit balance shown in the statement of profit or loss for the year, shows the amount of the final earnings to be included under "Prior year losses".
According to the second paragraph of article 45 of the ROSSP, the Company is obliged to constitute this reserve for the risk derived from civil liability insurance in motor land vehicles, establishing 35% as an upper limit of constitution of the risk premiums of own retention. In 2021, this limit was exceeded and therefore no equalisation reserve was posted. However, in 2022, due to the high loss ratio, the Company decided to apply the equalisation reserve, which meant that the reserve once again fell below the limit and was therefore re-posted in accordance with the regulations.
Technical provisions for ceded reinsurance are calculated in the same way as described for direct insurance, taking into account, where appropriate, the specific terms of the reinsurance contracts underwritten for each modality or segment.
In accordance with current legislation, the Company is obligated to pay compensation to those employees whose employment relationship is terminated under certain conditions. Therefore, termination benefits that can be reasonably quantified are reported as an expense in the year in which the relevant decision is reached and a valid expectation is created vis-à-vis third parties regarding the dismissal.
The Company has post-employment pension obligations classified as defined contribution plans and as defined benefit plans.
The Company's obligations with its employees with regard to retirement or similar pension plans were fully externalised at year-end 2022 and 2021, in compliance with the legislation in force regarding the externalisation of pension obligations (Royal Decree 1588/1999, of 15 October, approving the Regulations on the externalisation of company pension obligations with employees and beneficiaries).
The aforementioned insurance policies are considered "plan assets" as they are not owned by the Company, rather by a separate legal entity that is not a related party, as they are only available to pay or finance employee remuneration and cannot return to the Company, except where the assets attached to the plan are sufficient to honour all of the obligations.
This collective bargaining agreement also includes coverage for death and disability of employees during the period in which they remain in active service.
The current General State Collective Agreement for Insurance, Reinsurance and Occupational Accident Mutual Societies ushers in a new employee benefits system implemented through a collective life insurance policy suitable for the externalisation of pension commitments in accordance with the provisions of Royal Decree 1588/1999, of 29 November. The Company will contribute an annual premium per employee of 1.9% of their base salary to this insurance policy by no later than 30 September of each year, bearing in mind that employees who had provided services at the same company for 10 years of more will be entitled to have their vested rights recognised in the insurance policy.
This insurance policy applies to employees hired from 1 January 2017 onward and those who have voluntarily opted to transfer to this new modality. For employees adhered to the old plan who opted to avail themselves of this option, there was a transfer of the mathematical reserve.
The Company has also assumed a retirement commitment with certain executives, which has been externalised in the form of an insurance policy.
The Company records the contributions to be made to defined contribution plans progressively as the employees render their services. The amount of accrued contributions is recorded as an employee benefits expense and as a liability after deducting any amounts already paid. In the event that the amounts paid exceed the accrued expense, the corresponding assets are only recognised to the extent that they can be applied to reductions in future payments or result in a cash refund.
Employees hired prior to 1 January 2017 may choose between the system described above and the financial incentive for retirement, whereby if an employee asks to retire in the month in which he or she reaches the normal retirement age defined by Social Security legislation to be eligible for the retirement pension, the company will pay, in a lump sum, an amount equal to one month of salary per five years of service, capped at 10 months, the limit of which will be reached at 30 years of service at the company where the employee is retiring.
The Company includes in defined benefit plans those funded through the payment of insurance premiums where there is a legal or constructive obligation to pay benefits directly to employees when they fall due or to pay additional amounts if the insurer fails to pay benefits for services rendered by employees in the year or in prior years.
The expense or income relating to defined benefit plans is recognised under employee benefits expenses and is obtained by adding the net amount of the current year services cost and the net interest cost of the net defined benefit liability or asset. The remeasured amount of the net defined benefit liability or asset is recognised in other comprehensive income. This amount comprises actuarial gains and losses, the net return on plan assets and any changes in the effects of the asset ceiling, excluding amounts included in the net interest on the liability or asset. The costs of administering plan assets and any plan-specific taxes, beyond those included in the actuarial assumptions, are deducted from the net return on plan assets. Amounts deferred in other comprehensive income are reclassified to retained earnings in the same period.
In addition, if the plan assets include eligible insurance policies whose cash flows correspond exactly in amounts and timing to some or all of the benefits payable under the plan, their fair value is equal to the present value of the related payment obligations.
The Company's Chief Executive Officer and Management Committee participate in a Group remuneration plan of which the Company is the parent, based on shares as a consequence of the listing of the Company. The purpose of this Plan approved by the General Shareholders' Meeting on 18 March 2021 is to offer its members the possibility of receiving a certain number of shares in the next three years of the Entity's IPO date (Note 22).
The Company acknowledges services received in a transaction with sharebased payments, at the time such services are received. Since the services are settled in equity instruments, a decrease in equity is recognised.
The Company recognises transactions with share-based payments settled by the Company's equity instruments for the fair value of the goods or services received, unless such fair value cannot be reliably estimated, in which case the value is determined by reference to the fair value of the equity instruments distributed.
Deliveries of equity instruments in consideration of services provided by Employees of the Group or third parties providing similar services are valued by reference to the fair value of the equity instruments offered.
The Company recognises the estimated amount due to policyholders from the insurer of the injured party and the recoveries made by the latter upon enforcing the settlement agreements.
The Company has other revenue not derived from the insurance business, such as roadside assistance services or vehicle repairs and appraisals, all of which are provided to third parties outside the Group, as well as commissions on the sale of insurance products of other entities, remuneration for call forwarding and income from credit card surcharges.
Non-technical income and expenses are recognised as they accrue and taking into account the correlation between the income generated and the corresponding expenses.
As a general rule, transactions between the Company and a group company are initially recognised at fair value. If the agreed price differs from its fair value, the difference is recorded to reflect the economic reality of the transaction. These transactions are subsequently measured in accordance with the relevant standards.
Contingent liabilities are possible obligations arising from past events whose materialisation is conditional upon the occurrence or non-occurrence of one or more future events beyond the Company's control. These contingent liabilities are not recognised in the accounts, though they may be disclosed in the notes to the financial statements.
Provisions are recognised for obligations such as litigation in progress, indemnities or other obligations of undetermined amount or timing when the Company has a present obligation arising from a past event, and it is probable that an outflow of resources will be required to settle the obligation based on a reliable estimate of the amount of the obligation.
Provisions are measured at the present value of the best possible estimate of the amount required to settle or transfer the obligation, taking into account available information on the event and its consequences. Any adjustments arising from the updating of these provisions are recognised as a financial expense as it accrues. If the liabilities mature within one year, they are recognised at the nominal value of the obligation.
Meanwhile, compensation to be received from a third party at the time the obligation is settled —provided there is no doubt that such reimbursement will be received— is recognised as an asset, except where there is a legal relationship through which part of the risk has been externalised and by virtue of which the Company is not liable. In this situation, the compensation will be taken into account when estimating the amount at which the corresponding provision, if any, should be posted.
Income is recorded at the fair value of the consideration to be received and represents amounts receivable for goods delivered and services rendered in the ordinary course of the Company's business, less discounts and value added tax. Expenses are recognised as they accrue and taking into account the correlation between the income generated and the corresponding expenses.
However, the Company only records profits that have realised by year-end, while foreseeable risks and possible losses arising in the year or in a previous year are reported as soon as they become known.
Financial income and expenses arising from investments related to insurance activity are recognised in the statement of profit or loss for the non-life insurance business. The remainder is recorded in the statement of profit or loss for other activities.
Other income and expenses are distributed accordingly on the basis of net premiums written, except expenses attributable to claims, which are recognised on the basis of the provision for claims.
Business premiums are recognised as income over the term of the contracts on an accruals basis and are accrued by posting the provision for unearned premiums.
Premiums from ceded reinsurance are recognised on the basis of the reinsurance contracts underwritten and by applying the same criteria used for direct insurance.
The reclassification of expenses by type to expenses by purpose has been made on the basis of the following criteria:
The following purposes have been established:
Expenses have been allocated to the different segments based on the Business Unit at which the activity originated.
Under operational leasing arrangements, the lessor retains ownership of the leased asset and substantially all the risks and rewards relating to the asset.
Income and expenses arising from operating lease agreements are charged to the statement of profit or loss in the year in which they accrue.
Any collection or payment that may be made on entering into an operating lease is treated as a collection or advance payment to be charged to profit and loss over the lease term, as the benefits and rewards of the leased asset are transferred or received.
The Company's functional currency is the euro. Consequently, transactions in non-euro currencies are deemed to be denominated in foreign currency and are recognised at the exchange rates prevailing on the relevant transaction date.
At year-end, monetary assets and liabilities denominated in foreign currency are converted into euro at the exchange rate prevailing at the balance sheet date. The profit or loss for the year is taken to the statement of profit or loss.
Changes in the fair value of money instruments denominated in foreign currency classified as available for sale are analysed for translation differences resulting from changes in the amortised cost of the security and other changes in the carrying amount. The translation difference is recognised in profit and loss and other changes in the carrying amount are taken to equity.
This heading mainly shows accrued interest not yet due on financial investments to the extent that this does not form part of the repayment value obtained by applying the contractual interest rate of the financial instrument.
The share capital is represented by common shares. The costs of issuing new shares or options are charged directly to equity, as a reduction in reserves.
Where the Company's own shares are acquired, the consideration paid, including any directly attributable incremental costs, is deducted from equity until the shares are redeemed, reissued or otherwise disposed of. When these shares are sold or subsequently reissued, any amount received, net of any directly attributable incremental transaction costs, is taken to equity.
The Company's capital management policy aims to maintain a strong capital position.
The Board of Directors is ultimately responsible for the control and management of the Group's risks and solvency, and therefore monitors the Group's capital position, solvency requirements and available solvency.
Capital management is based on ensuring that the Company has sufficient capitalisation to meet financial obligations; optimising the capital structure through an efficient allocation of resources and managing capital adequacy taking into account the economic, accounting, capital requirements and capital targets set in the risk appetite.
To achieve this, the Company carries out an annual Own Risk and Solvency Assessment (ORSA), based on the outlook for the Group's business and the market. This allows the Group to prospectively project its assets and liabilities and earnings, which in turn can be used to evaluate the likely future performance of the various risks under management, quantify them and estimate changes in solvency and available solvency requirements.
The Parent is required to quantify its solvency ratio, meaning the ratio between available own funds and the solvency capital requirement.
The calculation of the Solvency Capital Requirement is regulated by Directive 2009/138 of the European Parliament and of the Council of 25 November 2009 on the taking-up and pursuit of the business of Insurance and Reinsurance (Solvency II), as implemented by Commission Delegated Regulation 2015/35 of 10 October 2014 supplementing Directive 2009-138 EC and its subsequent amendments.
The Solvency Capital Requirement is calculated for the following sub-risks which are the main sub-risks of an insurance company: underwriting risk, market risk, counterparty risk and operational risk.
The aim is to maintain an adequate level of solvency. When determining the adequate level of solvency, the risk profile, the results of capital planning for the coming years at the Company at an individual level, the minimum levels required by the regulations and the existing criteria and regulations for optimal capital management were all taken into consideration. The Company's solvency ratio was 188% in 2022 and 186% in 2021, taking into account the distribution of the extraordinary dividend charged to reserves of 120 million euros.
At 31 December 2022 and 2021, the balances of property, plant and equipment in the accompanying balance sheets and the changes therein in those years break down as follows:
| Land | Buildings | Plant | IT equipment | Furniture and other property, plant and equipment |
Assets in course of construction |
Total property, plant and equipment |
|
|---|---|---|---|---|---|---|---|
| Cost at 31.12.21 | 16,965 | 23,811 | 17,844 | 14,703 | 5,541 | 98 | 78,964 |
| Additions | - | 42 | 827 | 596 | 89 | 250 | 1,803 |
| Retirements | - | - | - | (3,624) | - | - | (3,624) |
| Transfers | - | - | 88 | - | - | (88) | - |
| Cost at 31.12.22 | 16,965 | 23,853 | 18,758 | 11,675 | 5,631 | 260 | 77,142 |
| Accumulated depreciation at 31/12/21 |
- | (6,835) | (13,257) | (11,231) | (3,950) | - | (35,273) |
| Additions | - | (477) | (950) | (1,401) | (324) | - | (3,152) |
| Retirements | - | - | - | 3,624 | - | - | 3,624 |
| Accumulated depreciation at 31/12/22 |
- | (7,312) | (14,207) | (9,008) | (4,274) | - | (34,801) |
| Impairment allowances at 31.12.21 | (2,115) | - | - | - | - | - | (2,115) |
| Application (allowance) in the period |
- | - | - | - | - | - | - |
| Impairment allowances at 31.12.22 | (2,115) | - | - | - | - | - | (2,115) |
| Carrying amount at 31/12/2022 | 14,850 | 16,541 | 4,552 | 2,667 | 1,356 | 260 | 40,226 |
| Land | Buildings | Plant | IT equipment | Furniture and other property, plant and equipment |
Assets in course of construction |
Total property, plant and equipment |
|
|---|---|---|---|---|---|---|---|
| Cost at 31.12.20 | 16,965 | 23,417 | 16,874 | 21,777 | 5,472 | 507 | 85,012 |
| Additions | - | - | 856 | 2,134 | 70 | 98 | 3,158 |
| Retirements | - | - | - | (9,208) | - | - | (9,208) |
| Transfers | - | 394 | 113 | - | - | (507) | - |
| Cost at 31.12.21 | 16,965 | 23,811 | 17,844 | 14,703 | 5,472 | 98 | 78,962 |
| Accumulated depreciation at 31.12.20 |
- | (6,364) | (12,312) | (19,137) | (3,629) | - | (41,442) |
| Additions | - | (471) | (945) | (1,296) | (321) | - | (3,033) |
| Retirements | - | - | - | 9,202 | - | - | 9,202 |
| Accumulated depreciation at 31/12/21 |
- | (6,835) | (13,257) | (11,231) | (3,950) | - | (35,273) |
| Impairment allowances at 31.12.20 | (2,115) | - | - | - | - | - | (2,115) |
| Application (allowance) in the period |
- | - | - | - | - | - | - |
| Impairment allowances at 31.12.21 | (2,115) | - | - | - | - | - | (2,115) |
| Carrying amount at 31/12/2021 | 14,850 | 16,976 | 4,586 | 3,472 | 1,592 | 98 | 41,574 |
In 2022, a total of € 3,624 thousand of information processing equipment was derecognised. In 2021, the Company derecognised property, plant and equipment amounting to € 9,208 thousand.
At 31 December 2022 and 2021, no impairment losses had been recognised.
Fully depreciated items of property, plant and equipment assets still in use at 31 December 2022 and 2021 amounted to:
| 2022 | 2021 | |
|---|---|---|
| Plant | 9,860 | 9,299 |
| IT equipment | 6,369 | 8,265 |
| Furniture and other property, plant and equipment | 2,540 | 2,416 |
| 18,769 | 19,980 |
The Company has taken out insurance policies with third parties to cover risks that could affect its property, plant and equipment. The coverage provided under these policies is considered sufficient.
There is no property, plant and equipment subject to guarantees or reversion events. The depreciation rates used are described in Note 4-b to these financial statements.
The following table provides a breakdown of the fair value at 31 December 2022 and 2021 of the items included under property, plant and equipment, such fair value as determined by an authorised property valuation company (see Note 4 b):
| 2022 | |||||
|---|---|---|---|---|---|
| Description | Cost value |
Accumulate d depreciation |
Impairme nt |
Net carrying amount |
Market value |
| Land and buildings at I. Newton, 7 (Tres Cantos) |
5,394 | (1,920) | - | 3,474 | 11,314 |
| Land and buildings at I. Newton, 9 (Tres Cantos) |
7,371 | (1,423) | (734) | 5,214 | 5,457 |
| Land and buildings at Ronda Europa, 7 (Tres Cantos) |
21,853 | (3,766) | (1,275) | 16,812 | 17,413 |
| Land and buildings at Torres Quevedo, 1 (Tres Cantos) |
6,199 | (201) | (105) | 5,893 | 7,860 |
| 40,817 | (7,310) | (2,114) | 31,393 | 42,044 |
| 2021 | |||||
|---|---|---|---|---|---|
| Description | Cost value Accumulated depreciation |
Impairme nt |
Net carrying amount |
Market value | |
| Land and buildings at I. Newton, 7 (Tres Cantos) |
4,958 | (1,823) | - | 3,135 | 11,231 |
| Land and buildings at I. Newton, 9 (Tres Cantos) |
7,371 | (1,345) | (734) | 5,292 | 5,369 |
| Land and buildings at Ronda Europa, 7 (Tres Cantos) |
21,853 | (3,528) | (1,275) | 17,050 | 17,287 |
| Land and buildings at Torres Quevedo, 1 (Tres Cantos) |
6,593 | (137) | (105) | 6,351 | 6,026 |
| 40,775 | (6,833) | (2,114) | 31,828 | 39,913 |
The market value is based on the comparison method (based on the replacement principle), which values property assets by comparison with other property values on the market and, on the basis of concrete information on actual transactions and firm offers, derives current cash purchase prices for these properties on the basis of homogenisation coefficients (Level 2).
This item corresponds to the net cost of a property that the Company leases from another Group company, namely Centro Avanzado de Reparaciones, CAR. S.L.U. The Company has operated its business out of this property since December 2011.
The following table shows changes in this heading in 2022 and 2021.
| Land | Buildings | Total investment property |
||
|---|---|---|---|---|
| Cost at 31/12/21 | 940 | 1,407 | 2,347 | |
| Additions | - | - | - | |
| Retirements | - | - | - | |
| Cost at 31/12/22 | 940 | 1,407 | 2,347 | |
| Accumulated amortisation at 31/12/21 |
- | (287) | (287) | |
| Additions | - | (28) | (28) | |
| Retirements | - | - | - | |
| Accumulated amortisation at 31/12/22 |
- | (315) | (315) | |
| Impairment allowances at 31/12/21 |
(137) | - | (137) | |
| Allowance in the period | - | - | - | |
| Amounts utilised in the period |
- | - | - | |
| Impairment allowances at 31/12/22 |
(137) | - | (137) | |
| Carrying amount at 31/12/2022 |
803 | 1,092 | 1,895 |
| Land | Buildings | Total investment property |
||
|---|---|---|---|---|
| Cost at 31.12.20 | 940 | 1,407 | 2,347 | |
| Additions | - | - | - | |
| Retirements | - | - | - | |
| Cost at 31/12/21 | 940 | 1,407 | 2,347 | |
| Accumulated amortisation at 31.12.20 |
- | (259) | (259) | |
| Additions | - | (28) | (28) | |
| Retirements | - | - | - | |
| Accumulated amortisation at 31/12/21 |
- | (287) | (287) | |
| Impairment allowances at 31.12.20 |
(137) | - | (137) | |
| Allowance in the period | - | - | - | |
| Amounts utilised in the period |
- | - | - | |
| Impairment allowances at 31/12/21 |
(137) | - | (137) | |
| Carrying amount at 31/12/2021 |
803 | 1,120 | 1,923 |
Details of fair value at 31 December 2022 and 2021 are as follows:
| 2022 | |||||
|---|---|---|---|---|---|
| Description | Cost value | Accumulated depreciation |
Impairmen t |
Net carrying amount |
Market value |
| Land and buildings at Avda. El Sol, 9 (Torrejón de Ardoz) |
2,347 | (315) | (137) | 1,895 | 1,911 |
| 2,347 | (287) | (137) | 1,895 | 1,911 |
| 2021 | |||||
|---|---|---|---|---|---|
| Description | Cost value | Accumulated depreciation |
Impairment | Net carrying amount |
Market value |
| Land and buildings at Avda. El Sol, 9 (Torrejón de Ardoz) |
2,347 | (287) | (137) | 1,923 | 1,951 |
| 2,347 | (259) | (137) | 1,923 | 1,951 |
The rent paid to subsidiary company Centro Avanzado de Reparaciones CAR, S.L.U. for the lease of this property amounted to € 107 thousand in 2022 (€ 100 thousand in 2021), as recognised under "Income from investment property" in the technical statement of profit or loss. The last appraisal of the property was carried out on November 19, 2020.
All properties were insured against the risk of fire and third-party liability in 2022 and 2021.
At 31 December 2022 and 2021 the balance of this heading related entirely to software. Changes in 2022 and 2021 are as follows:
| Thousand euro | Software | Assets in course of construction |
Total intangible assets |
|---|---|---|---|
| Cost at 31/12/21 | 92,675 | 2,304 | 94,979 |
| Additions | 1,320 | 3,518 | 4,838 |
| Retirements | - | - | - |
| Transfers | 930 | (930) | - |
| Cost at 31/12/22 | 94,924 | 4,892 | 99,817 |
| Accumulated amortisation at 31/12/21 | (80,918) | - | (80,918) |
| Additions | (4,332) | - | (4,332) |
| Retirements | - | - | - |
| Accumulated amortisation at 31/12/22 | (85,350) | - | (85,250) |
| Accumulated impairment losses | - | - | - |
| Carrying amount at 31/12/2022 | 9,574 | 4,892 | 14,467 |
| Thousand euro | Software | Assets in course of construction |
Total intangible assets |
|---|---|---|---|
| Cost at 31.12.20 | 94,319 | 22 | 94,341 |
| Additions | 4,042 | 2,304 | 6,346 |
| Retirements | (5,709) | - | (5,709) |
| Transfers | 22 | (22) | - |
| Cost at 31/12/21 | 92,675 | 2,304 | 94,979 |
| Accumulated amortisation at 31.12.20 | (81,779) | - | (81,779) |
| Additions | (4,705) | - | (4,705) |
| Retirements | 5,566 | - | 5,566 |
| Accumulated amortisation at 31/12/21 | (80,918) | - | (80,918) |
| Accumulated impairment losses | - | - | - |
| Carrying amount at 31/12/2021 | 11,757 | 2,304 | 14,061 |
The additions recognised in 2022 and 2021 mainly relate to technological developments and the purchase of software licences.
Fully amortised intangible fixed assets at 31 December 2022 and 2021 amounted to € 74,126 thousand and € 70,764 thousand, respectively.
At 31 December 2022 and 2021 there were no intangible assets subject to guarantees or reversals.
The following table provides a breakdown of this heading at 31 December 2022 and 2021.
| 2022 | 2021 | |
|---|---|---|
| Acquisition costs | 94,608 | 87,219 |
| Accruals | 9,425 | 8,558 |
| 104,033 | 95,777 |
Deferred acquisition expenses relate to expenses directly attributable to the collection of premiums that accrue annually over the term of the policy, mainly commission expenses and marketing expenses.
Deferred acquisition expenses are recognised in accordance with the accounting principles explained in Note 4 c). Changes in 2022 and 2021 are as follows:
| 2022 | 2021 | |
|---|---|---|
| Balance at the beginning of the year |
87,219 | 83,055 |
| Additions | 94,608 | 87,219 |
| Retirements | (87,219) | (83,055) |
| Balance at the end of the year |
94,608 | 87,219 |
Additions shows acquisition expenses for the year that are to be accrued in the following year, in correlation with the income earned from premiums written in each year. Unearned premium income corresponds to the unearned premium provision at that date. Retirements for each year relate to the derecognition of accrued acquisition expenses from the previous year.
The sub-heading "Accruals and prepayments" mainly includes accrued and unmatured explicit interest on bank deposits and available-for-sale fixed-income investments amounting to € 6,119 thousand (€ 7,059 thousand in 2021). It also shows the cost of certain prepaid services that will accrue in 2022, for a total of € 3,306 thousand (€ 1,499 thousand in 2021).
Financial assets and liabilities fell into the following categories at the end of 2022 and 2021:
| Financial assets | Cash and cash |
Available-for-sale financial assets |
Loans and receivable |
Holdings in group |
Total | ||
|---|---|---|---|---|---|---|---|
| equivalents | At fair value | At cost | s | Derivatives companies and associates |
|||
| Equity instruments: | - | 85,093 | 6 | - | - | 69,494 | 154,593 |
| - Financial investments in capital | - | 38,754 | 6 | - | - | 69,494 | 108,254 |
| - Units/interests in mutual funds | - | 46,339 | - | - | - | - | 46,339 |
| - Units/interests in private equity funds | - | - | - | - | - | - | - |
| - Other equity instruments | - | - | - | - | - | - | - |
| Debt securities: | - | 612,672 | - | - | - | - | 612,672 |
| - Fixed-income securities | - | 612,672 | - | - | - | - | 612,672 |
| - Other debt securities | - | - | - | - | - | - | - |
| Derivatives | - | - | - | - | 7,844 | - | 7,844 |
| Loans: | - | - | - | 22,139 | - | - | 22,139 |
| - Loans and advances on policies | - | - | - | - | - | - | - |
| - Loans to group companies | - | - | - | 22,139 | - | - | 22,139 |
| - Mortgage loans | - | - | - | - | - | - | - |
| - Other loans | - | - | - | - | - | - | - |
| Deposits with credit institutions | - | - | - | - | - | - | |
| Deposits posted on accepted | - | - | - | - | - | - | - |
| reinsurance | |||||||
| Receivables on direct insurance | - | - | - | 58,524 | - | - | 58,524 |
| business: | |||||||
| Policyholders: | - | - | - | 58,524 | - | - | 58,524 |
| - Premium payments outstanding | - | - | - | 59,485 | - | - | 59,485 |
| - Provision for outstanding premiums | - | - | - | (961) | - | - | (961) |
| Receivables on reinsurance business: | - | - | - | 12,290 | - | - | 12,290 |
| - Outstanding balances with reinsurers | - | - | - | 12,290 | - | - | 12,290 |
| - Provision for impairment of balances subject to reinsurance |
- | - | - | - | - | - | - |
| Receivables on co-insurance business: | - | - | - | - | - | - | - |
| - Outstanding balances with coinsurers | - | - | - | - | - | - | - |
| - Provision for impairment of balances subject to coinsurance |
- | - | - | - | - | - | - |
| Called up share capital | - | - | - | - | - | - | - |
| Other receivables: | - | - | - | 47,148 | - | - | 47,148 |
| - Tax and social security receivable | - | - | - | 1,040 | - | - | 1,040 |
| - Other receivables | - | - | - | 46,108 | - | - | 46,108 |
| Other financial assets | - | - | - | - | - | - | - |
| Cash | 44,040 | - | - | - | - | - | 44,040 |
| Balance at 31 December 2022 | 44,040 | 697,765 | 6 | 140,101 | 7,844 | 69,494 | 959,520 |
| Cash and | Available-for-sale financial assets |
Loans and | Holdings in group |
||||
|---|---|---|---|---|---|---|---|
| Financial assets | cash equivalents |
At fair value | At cost | receivables | companies and associates |
Total | |
| Equity instruments: | - | 125,734 | 6 | - | 65,785 | 191,525 | |
| - Financial investments in capital | - | 49,508 | 6 | - | 65,785 | 115,299 | |
| - Units/interests in mutual funds | - | 76,226 | - | - | - | 76,226 | |
| - Units/interests in private equity funds | - | - | - | - | - | - | |
| - Other equity instruments | - | - | - | - | - | - | |
| Debt securities: | - | 703,960 | - | - | - | 703,960 | |
| - Fixed-income securities | - | 703,960 | - | - | - | 703,960 | |
| - Other debt securities | - | - | - | - | - | - | |
| Derivatives | - | - | - | - | - | - | |
| Loans: | - | - | - | 22,981 | - | 22,981 | |
| - Loans and advances on policies | - | - | - | - | - | - | |
| - Loans to group companies | - | - | - | 22,981 | - | 22,981 | |
| - Mortgage loans | - | - | - | - | - | - | |
| - Other loans | - | - | - | - | - | - | |
| Deposits with credit institutions | - | - | - | - | - | ||
| Deposits posted on accepted | |||||||
| reinsurance | - | - | - | - | - | - | |
| Receivables on direct insurance | |||||||
| business: | - | - | - | 53,538 | - | 53,538 | |
| Policyholders: | - | - | - | 53,538 | - | 53,538 | |
| - Premium payments outstanding | - | - | - | 54,472 | - | 54,472 | |
| - Provision for outstanding premiums | - | - | - | (934) | - | (934) | |
| Receivables on reinsurance business: | - | - | - | 7,969 | - | 7,969 | |
| - Outstanding balances with | - | - | - | 7,969 | - | 7,969 | |
| reinsurers | |||||||
| - Provision for impairment of | - | - | - | - | - | - | |
| balances subject to reinsurance | |||||||
| Receivables on co-insurance | - | - | - | - | - | - | |
| business: | |||||||
| - Outstanding balances with coinsurers |
- | - | - | - | - | - | |
| - Provision for impairment of | |||||||
| balances subject to coinsurance | - | - | - | - | - | - | |
| Called up share capital | - | - | - | - | - | - | |
| Other receivables: | - | - | - | 46,393 | - | 46,393 | |
| - Tax and social security receivable | - | - | - | 1,040 | - | 1,040 | |
| - Other receivables | - | - | - | 45,353 | - | 45,353 | |
| Other financial assets | - | - | - | - | - | - | |
| Cash | 98,911 | - | - | - | - | 98,911 | |
| Balance at 31 December 2021 | 98,911 | 829,694 | 6 | 130,881 | 65,785 | 1,125,277 |
| Financial liabilities | payable | Debt and accounts | Hedging derivatives |
|
|---|---|---|---|---|
| 2022 | 2021 | 2022 | 2021 | |
| Due on direct insurance business - Due to policyholders - Due to agents, brokers and intermediaries - Conditional claims |
2,490 2,009 481 - |
2,526 1,939 587 - |
- - - - |
- - - - |
| Due on reinsurance business: Other debts - Tax and social security payable - Due to group companies and associates (Notes 5, 13 and 15) - Other payables (Note 13) |
1,363 40,824 14,835 276 25,713 |
1,244 156,101 16,694 364 139,043 |
- - - - - |
- - - - - |
| Hedging derivatives | - | - | - | 8,922 |
| Total | 44,677 | 159,871 | - | 8,922 |
The classification of financial assets by maturity, for those with a given or determinable maturity for each asset category, was as follows at 31 December 2022 and 2021:
| Financial assets | |||||||
|---|---|---|---|---|---|---|---|
| 2023 | 2024 | 2025 | 2026 | 2027 | Subseque nt periods |
Total | |
| Investments in group companies and associates |
2,738 | 18,663 | 363 | 363 | - | - | 22,139 |
| - Loans to group companies (Note 15) | 2,750 | 18,663 | 363 | 363 | - | - | 22,139 |
| - Debt securities (Note 15) | - | - | - | - | - | - | - |
| Other financial investments: | 124,097 | 46,689 | 58,652 | 102,541 | 35,460 | 245,323 | 612,672 |
| - Debt securities | 124,097 | 46,689 | 58,652 | 102,541 | 35,460 | 245,323 | 612,672 |
| - Deposits with credit institutions | - | - | - | - | - | - | - |
| 31 December 2022 | 126,835 | 65,352 | 59,015 | 102,904 | 35,460 | 245,323 | 634,811 |
| Financial assets | |||||||
|---|---|---|---|---|---|---|---|
| 2022 | 2023 | 2024 | 2025 | 2026 | Subseque nt periods |
Total | |
| Investments in group companies and associates |
3,229 | 363 | 18,663 | 363 | 363 | - | 22,981 |
| - Loans to group companies (Note 15) | 3,229 | 363 | 18,663 | 363 | 363 | - | 22,981 |
| - Debt securities (Note 15) | - | - | - | - | - | - | - |
| Other financial investments: | 42,999 | 112,349 | 50,679 | 58,554 | 104,634 | 334,745 703,960 | |
| - Debt securities | 42,999 | 112,349 | 50,679 | 58,554 | 104,634 | 334,745 703,960 | |
| - Deposits with credit institutions | - | - | - | - | - | - | - |
| 31 December 2021 | 46,228 | 112,712 | 69,342 | 58,917 | 104,997 | 334,745 726,941 |
Receivables on insurance operations for December 2022 and 2021 mature in 2023 and 2022, respectively.
Debts included under financial liabilities at 31 December 2022 and 2021 mature in 2023 and 2022, respectively.
At the end of 2022 and 2021, this heading showed € 38,760 thousand and € 49,514 thousand in shares, respectively, together with units and interests in investment and private equity funds amounting to € 46,339 thousand and € 76,226 thousand, respectively.
The total investment in equities included the sum of € 10,175 thousand at 31 December 2022 (€ 9,950 thousand in 2021) in two listed real estate investment trusts in which a Bankinter Group financial institution holds a stake.
It also includes € 612,672 thousand and € 703,960 thousand, respectively, in fixed-income securities, of which € 3,474.98 thousand related to group companies in 2022 and € 3,316 thousand in 2021 (see Note 15).
At the end of 2022 and 2021, there were no impairment losses due to credit risk or the impairment of assets under this heading.
The amount of accrued and non-overdue interest on fixed income assets under this heading amounts to € 6,119 thousand at the end of 2022 (€ 7,058 thousand at the end of 2021) and is included under the heading "Other assets – Prepayments" on the assets side of the accompanying balance sheet. The average return on the fixed income portfolio in 2022 was 2.48% (2.69% in 2021).
This heading breaks down as follows at 31 December 2022 and 2021:
| 2022 | 2021 | |
|---|---|---|
| Loans to companies | ||
| Loan to LDActivos, S.L.U. | 18,300 | 18,300 |
| Loan to Centro Avanzado de Reparaciones, CAR, S.L.U. | 1,454 | 1,817 |
| Loans to LD Asistencia, S.L.U. | 1,180 | 1,578 |
| Loans to LDActivos, S.L.U. | 1,088 | 1,040 |
| Créditos Ámbar Medline, S.L.U. | (2) | (3) |
| Loans to Moto Club LDA, S.L.U. | 11 | 12 |
| Loans to Centro Avanzado de Reparaciones, CAR, S.L.U. | 33 | 133 |
| Loans to LDA Reparaciones, S.L.U. | 76 | 104 |
| Balance at 31 December | 22,139 | 22,981 |
In July 2014, the Company granted its subsidiary LDActivos, S.L.U. a loan of € 19,300 thousand for the acquisition in cash of a property the latter company intended to lease out as part of its corporate purpose. In November 2020, the partial repayment of this loan was carried out for an amount of € 4,000 thousand, leaving the principal at € 15,300 thousand. In December 2021 the loan was extended by € 3,000 thousand, leaving a new principal amount of € 18,300 thousand bearing interest at three per cent per annum, payable monthly, with a repayment period of up to ten years, and the lender may repay the loan early. The Company's directors consider that this loan will be repaid in full before the contract expires, as the Company, as sole shareholder, had undertaken to provide its subsidiary with all the liquidity needed to repay the loan.
In 2022, the interest income on this loan amounted to € 549 thousand (€ 466 thousand in 2021), as recognised under "Income from property, plant and equipment and investments – Income from investment property" in the accompanying technical account for non-life insurance. All such interest had been collected at 31 December 2022.
The loan granted to Centro Avanzado de Reparaciones CAR, S.L.U. is a participation loan signed on 21 July 2011, with a principal of € 1,232 thousand. On 19 April 2018, an agreement was signed to extend this loan by a further € 600 thousand. The loan was then ended for a further € 1,560 thousand in May 2020. A total balance of € 1,454 thousand remained outstanding at 31 December 2022, subject to the same 10-year term with interest consisting of a fixed component (Euribor + 1 percentage point) and a variable component (8% of pre-tax profits obtained by the borrower, payable from when there is no impairment). A fixed amount of € 363 thousand in principal will be repaid at the end of each year.
| 2022 | 2021 | |
|---|---|---|
| Balance at the beginning of the year |
1,817 | 2,181 |
| Additions | - | - |
| Repayments | (363) | (364) |
| Balance at the end of the year | 1,454 | 1,817 |
Changes in the balances of this loan in 2022 and 2021 are as follows:
At 31 December 2022 there was a total of € 14 thousand in outstanding accrued interest (€ 4 thousand at 31 December 2021).
The loans to LD Asistencia, S.L.U., LDActivos, S.L.U., Ámbar Medline, S.L.U., Moto Club LDA, S.L.U., Centro Avanzado de Reparaciones CAR, S.L.U. and LDA Reparaciones, S.L.U. relate to the balances payable by these companies to Tax Consolidation Group 485/15, of which Línea Directa Aseguradora is the Parent (see Note 17). These amounts do not accrue interest and will be settled after final settlement of corporate income tax for the Tax Consolidation Group.
This heading shows loans to policyholders for premium receipts that are overdue and for premium fractions yet to be issued.
The correction for impairment of the premiums pending collection is calculated according to the criteria established by the Accounting Plan of Insurance Entities in its second section "recognition and measurement rules", taking into account the age of the outstanding payments and the experience for the tranche between zero and three months. Outstanding payments with an age of between three and six months are provisioned for impairment at 50% of their value, while those over six months are provisioned at 100%. The amount of outstanding payments with an age of more than three months has a non-significant amount.
Details of the items under this heading at year-end 2022 and 2021 are as follows:
| Receivable from policyholder s |
Impairment adjustment |
Total | |
|---|---|---|---|
| Balance at 31 December 2022 | 59,485 | (961) | 58,524 |
| Balance at 31 December 2021 | 54,472 | (934) | 53,538 |
This heading shows claims and debts with reinsurers at year end, broken down by type of reinsurance (see Note 13 to these financial statements for further information on debts and payables):
| 2022 | 2021 | |||
|---|---|---|---|---|
| Receiva ble |
Payable | Receiva ble |
Payable | |
| Reinsurance – Penalties and other guarantees |
- | 1,363 | - | 827 |
| Reinsurance XL | 2,401 | - | - | 417 |
| Quota share reinsurance | 9,889 | - | 7,969 | - |
| 12,290 | 1,363 | 7,969 | 1,244 |
The receivables and payables for the Reinsurance Quota Part correspond to the health business.
| 2022 | 2021 | |
|---|---|---|
| Tax and social security receivable | 1,040 | 1,040 |
| Bonds and deposits | 17 | 17 |
| Receivables from recoveries and claims | 42,551 | 42,920 |
| Receivables under claim settlement agreements | 2,690 | 1,743 |
| Sundry receivables | 262 | 144 |
| Receivable from group companies and associates (Note 15) | 588 | 529 |
| 47,148 | 46,393 |
The sub-heading "Receivables from recoveries and claims" corresponds to the balances to be recovered for claims whose recoverability is sufficiently guaranteed at the end of the year. The analysis to establish the guarantee of the balance to be recovered is carried out individually for each claim taking into account the objective circumstances that occurred in the processing of the same, such as: acceptance of fault by the other insurer, favourable court rulings, etc. The amount recognised in 2022 amounted to € 42,551 thousand (€ 42,920 thousand in 2021).
This sub-heading shows both the recoveries that come from recoveries of agreement claims modules in which the insured party of the Company is nonculpable (€ 24,808 thousand in 2022 and € 22,372 thousand in 2021) and recoveries that come from non-claims settlement claims (€ 17,743 thousand in 2022 and € 20,548 thousand in 2021).
At 31 December 2022 and 2021, the Company owned 100% of the share capital of its subsidiaries. This heading of the accompanying balance sheets at 31 December 2022 and 2021, including the relevant carrying amounts, breaks down as follows:
| 2022 | |||||
|---|---|---|---|---|---|
| Subsidiary | Carrying amount of the holding |
Capital and share premium |
Reserves | Profit/(loss) for the year |
Dividends paid |
| Línea Directa Asistencia, S.L.U. | 418 | 30 | 4,650 | 2,450 | 16,000 |
| Moto Club LDA, S.L.U. | 3 | 3 | 117 | 19 | - |
| Centro Avanzado de Reparaciones CAR, S.L.U. | 2,103 | 600 | 1,184 | 110 | - |
| Ambar Medline, S.L.U. | 303 | 303 | 109 | 2 | - |
| LDActivos, S.L.U. | 67,234 | 67,234 | 15,553 | 2,193 | - |
| LDA Reparaciones, S.L.U. | 300 | 300 | 335 | 142 | - |
| Impairment on holdings in related parties | (867) | - | - | - | - |
| Total | 69,494 | 68,470 | 21,948 | 4,916 | 16,000 |
| 2021 | |||||
|---|---|---|---|---|---|
| Subsidiary | Carrying amount of the holding |
Capital and share premium |
Reserves | Profit/(loss) for the year |
Dividends paid |
| Línea Directa Asistencia, S.L.U. | 418 | 30 | 16,178 | 2,472 | 2,500 |
| Moto Club LDA, S.L.U. | 3 | 3 | 98 | 20 | - |
| Centro Avanzado de Reparaciones CAR, S.L.U. |
2,103 | 600 | 1,016 | 167 | - |
| Ambar Medline, S.L.U. | 303 | 303 | 105 | 5 | - |
| LDActivos, S.L.U. | 63,634 | 63,634 | 12,705 | 1,848 | - |
| LDA Reparaciones, S.L.U. | 300 | 300 | 168 | 166 | - |
| Impairment on holdings in related parties | (976) | - | - | - | - |
| Total | 65,785 | 64,870 | 30,270 | 4,678 | 2,500 |
On 15 July 2022, the General Shareholders' Meeting of LDA Activos S.L.U., of which the Company is the Sole Shareholder, approved a capital increase amounting to € 3,600 thousand, bringing Capital and Issue premium to € 67,234 thousand at year-end 2022 (€ 63,634 thousand in 2021). On 24 September 2021, the Sole Shareholder of Ambar Medline, S.L.U decided to make a capital reduction with the aim of partially returning the capital contributions made by the Sole Shareholder through the proportional cancellation of shares. Following the reduction, the company's share capital stood at € 303 thousand.
A provision for impairment of the investment held in Centro Avanzado de Reparaciones CAR, S.L.U. was recognised at 31 December 2022 for a total of € 867 thousand (€ 976 thousand at 31 December 2021). Changes in the provision were as follows:
| 2022 | 2021 | |
|---|---|---|
| Balance at the beginning of the year |
977 | 1,144 |
| Allowances | - | - |
| Amounts utilised | (110) | 167 |
| Balance at the end of the year | 867 | 977 |
In 2022, the subsidiary Línea Directa Asistencia, S.L.U. granted a dividend of € 14,000 thousand charged to its freely available reserves and € 2,000 thousand as an interim dividend charged to profit for 2022 (€ 2,500 thousand in 2021). These dividends are recorded under the heading "Income from property, plant and equipment and investments – Income from investment property" in the accompanying non-technical account.
The Company has included one swap under this heading, the value of which amounted € 7,844 thousand at 31 December 2022 (€ -8,922 thousand at 31 December 2021).
| 2022 | ||||||
|---|---|---|---|---|---|---|
| Item | Initial value | Accumulat ed impairment |
Impairmen t adjustment |
Valuation adjustment |
Purchase s/Sales |
Final value |
| SWAP | (5,970) | - | - | 13,814 | - | 7,844 |
| SWAP | (2,952) | - | - | 3,602 | (650) | - |
| Total | (8,922) | - | - | 17,416 | (650) | 7,844 |
| 2021 | ||||||
|---|---|---|---|---|---|---|
| Item | Initial value | Accumulat ed impairment |
Impairmen t adjustment |
Valuation adjustment |
Purchase s/Sales |
Final value |
| SWAP | (15,167) | - | - | 6,245 | - | (8,922) |
| Total | (15,167) | - | - | 6,245 | - | (8,922) |
The fair value has been provided by the financial institution, which acts as counterparty.
The following table shows the type of contracts guaranteed:
| Type of asset | Counterparty | Number of contracts |
Carrying amount |
Market value |
Nominal value |
Rat e |
Currenc y |
|---|---|---|---|---|---|---|---|
| Current account | BBVA S.A. | 1 | (4,077) | (4,077) | (4,077) | ESTR | EUR |
| Subtotal – Current Account |
(4,077) | (4,077) | (4,077) | ESTR | EUR | ||
| Swaps | BBVA S.A. | 1 | 7,844 | 7,844 | 7,844 | EUR | |
| Subtotal – Swaps | 7,844 | 7,844 | 7,844 | EUR | |||
| Total | 3,767 | 3,767 | 3,767 | EUR |
The risk of these swaps arises from the interest rate or market risk of the swapped securities' own underlyings, as well as from the credit risk of the issuing institutions. The derivative product associated with the underlying is also exposed to these same risks.
At 31 December 2022, a total of € 7,844 thousand was recognised under "Hedging derivatives" on the assets side of the balance sheet (31 December 2021: € 8,922 thousand on the liabilities side), in relation to swaps. The Company with which this contract has been signed relies on the clearing house to calculate the current value of the outstanding flows between the two parties.
The hedged item consists of coupon payments of 2.45% on a BTPS bond on 50,000 thousand until maturity on 1 September 2033. In exchange, the Company receives payments of Euribor 6M + 1.03% on € 50,000 thousand of the BTPS bond until maturity on 1 September 2033. At 31 December 2021, the Company also had a hedged item consisting of coupon payments of 2.35% on a SPGB bond of € 25,000 thousand per annum through to maturity on 30 July 2033, which was cancelled in 2022.
The following table shows the breakdown of financial income and expenses, as per the category to which each asset has been assigned:
| Investment income | Cash and cash equival ents |
Loans and receivable s |
Available for-sale assets |
Property, plant and equipment and investment property |
Group companies and associates |
Other | Total |
|---|---|---|---|---|---|---|---|
| Interest on fixed-income securities | - | - | 17,301 | - | - | - | 17,301 |
| Income on equity instruments | - | - | 7,908 | - | - | - | 7,908 |
| Derivatives revenue | - | - | 573 | - | - | - | 573 |
| Interest on loans with group companies (Note 15) |
- | 567 | - | - | - | - | 567 |
| Interest on current accounts | 10 | - | - | - | - | - | 10 |
| Interest on bank deposits Effect of change in investment value, |
- | 280 | - | - | - | - | 280 |
| group | - | - | - | - | 110 | - | 110 |
| Income from premium instalments | - | 4,571 | - | - | - | - | 4,571 |
| Income from investment in property, plant and equipment Income from investments in group |
- | - | - | 127 | - | - | 127 |
| companies (Note 15) Gains/(losses) on realisation of |
- | - | - | - | 16,000 | - | 16,000 |
| investments | - | - | 12,647 | - | - | - | 12,647 |
| Positive exchange differences | - | - | 3,269 | - | - | - | 3,269 |
| Derivative valuation | - | - | - | - | - | 20,843 | 20,843 |
| Other | - | - | - | - | - | 223 | 223 |
| Balance at 31 December 2022 | 10 | 5,418 | 41,698 | 127 | 16,110 | 21,066 | 84,429 |
| Expenses from property, plant and equipment and investments |
Available-for sale assets |
Property, plant and equipment and investment property |
Non-current dividends payable |
Other | Total |
|---|---|---|---|---|---|
| Investment costs | |||||
| Fixed income valuation | 1,982 | - | - | - | 1,982 |
| Realisation of equity instruments | 2,540 | - | - | - | 2,540 |
| Realisation of fixed-income instruments | 2,924 | - | - | - | 2,924 |
| Depreciation of investment property | - | 28 | - | - | 28 |
| Provision for investment impairment | - | - | - | - | - |
| Bank charges | - | - | - | 131 | 131 |
| Long-term discounting of interest and dividends | - | - | - | - | - |
| Negative exchange difference | (498) | - | - | - | (498) |
| Derivative financial expenses | - | - | - | 1,376 | 1,376 |
| Investment management expenses and other | - | - | - | 2,062 | 2,062 |
| Derivative valuation | - | - | - | 20,843 | - |
| Other | - | - | - | - | - |
| Balance at 31 December 2022 | 6,948 | 28 | - | 24,412 | 31,388 |
| Investment income | Cash and cash equivalent s |
Loans and receivables |
Available for-sale assets |
Property, plant and equipment and investment property |
Group companies and associates |
Total |
|---|---|---|---|---|---|---|
| Interest on fixed-income securities | - | - | 18,774 | - | - | 18,774 |
| Income on equity instruments | - | - | 7,159 | - | - | 7,159 |
| Interest on loans with group companies (Note 15) |
- | - | 374 | - | - | 374 |
| Interest on current accounts | - | 475 | - | - | - | 475 |
| Interest on bank deposits | - | - | - | - | - | - |
| Effect of change in investment value | - | - | - | - | 167 | 167 |
| Income from premium instalments | - | 4,503 | - | - | - | 4,503 |
| Income from investment in property, plant and equipment Income from investments in group |
- | - | - | 164 | - | 164 |
| companies (Note 15) Gains/(losses) on realisation of |
- | - | - | - | 2,500 | 2,500 |
| investments | - | - | 8,652 | 21 | - | 8,673 |
| Profits from the valuation of derivatives | - | - | 13,480 | - | - | 13,480 |
| Positive exchange differences | - | - | 42 | - | - | 42 |
| Balance at 31 December 2021 | - | 5,569 | 48,481 | 185 | 2,667 | 56,902 |
| Expenses from property, plant and equipment and investments |
Available-for sale assets |
Property, plant and equipment and investment property |
Non-current dividends payable |
Other | Total |
|---|---|---|---|---|---|
| Investment costs | |||||
| Fixed income valuation | 3,530 | - | - | - | 3,530 |
| Equity valuation | 748 | - | - | - | 748 |
| Derivative valuation | - | - | - | 13,480 | 13,480 |
| Depreciation of investment property | - | 28 | - | - | 28 |
| Provision for investment impairment | - | - | - | - | - |
| Long-term discounting of interest and dividends | - | - | - | - | - |
| Negative exchange difference | 191 | - | - | - | 191 |
| Derivative financial expenses | - | - | - | 1,807 | 1,807 |
| Investment management expenses and other | - | 6 | - | 2,106 | 2,112 |
| Balance at 31 December 2021 | 4,469 | 34 | - | 17,393 | 21,896 |
47 Línea Directa Aseguradora, S.A. Compañía de Seguros y Reaseguros 2022 individual financial statements (Expressed in thousand euro) The "fixed income valuation" heading under Assets Available for Sale includes the monthly valuation differences of the hedge derivative operation during the year. The positive monthly differences are shown in the Income from investments table and the negative differences in the Expenditure for property, plant and equipment and investments table.
At 31 December 2022, the balance of "Income from investments in property, plant and equipment" in the above table included € 107 thousand in income from the lease arranged with group company Centro Avanzado de Reparaciones CAR, S.L.U. (see Note 15) (31 December 2021: € 100 thousand).
The level of assumible risk for the financial investments undertaken by the Company is explained in the Investment Guidelines approved by the Board of Directors. This document describes the types of permitted assets for investment purposes, along with the maximum proportion of these assets within the portfolio, and authorises the Company's Investment Committee to undertake investments.
The Investment Committee, which meets monthly, is responsible for analysing the portfolio's performance, approving new lines of investment, verifying compliance with the investment guidelines and keeping the Board of Directors regularly informed.
The counterparties with which the Company acquires or may acquire significant positions must invariably undergo a prior scoring process. These counterparties include companies that provide insurance for large vehicle fleets and, in particular, reinsurance companies. For the latter, a minimum credit rating of "A" is required as a prerequisite for inclusion within the reinsurance programme. Exceptions to this solvency threshold, together with the reinsurance table for each year, are expressly approved by the Board of Directors.
The rating of the debt securities classified in the "available for sale" portfolio is an average rating of that assigned to the issuer by three of the main rating agencies (Moody's, Fitch and DBRS) and presents the following classification at the end of 2022 and 2021:
| RATING – "Available for sale" portfolio | 2022 | 2021 |
|---|---|---|
| AAA | 13,152 | 6,235 |
| AA | 11,207 | 10,031 |
| A | 269,331 | 288,382 |
| BBB | 298,083 | 359,858 |
| BB | 10,298 | 27,803 |
| B | 985 | - |
| N/R | 9,616 | 11,561 |
| Total | 612,672 | 703,960 |
In 2022, positions without a rating largely related to representative securities whose issuer does not have a rating, but which nevertheless have an issue rating consistent with the Group's investment policies. In 2021, most of the amount related to a promissory note worth € 6,891 thousand.
The Company treats liquidity risk as the potential temporary inability to honour its payment obligations within the agreed timeframes, due to such obligations maturing before receivables from customers fall due or before financial investments reach maturity. The Company generates daily liquidity from premium income.
The Company manages liquidity risk prudently. The Company is firmly committed to having sufficient liquidity to be able to honour its payments to suppliers, policyholders and counterparties in due course. Consequently, cash management is always carried out with the utmost prudence, avoiding at all times any possible overdraft or overlimit situation. Therefore, forecasts are systematically drawn up of expected cash generation and cash requirements, which enable the Company's liquidity position to be determined and monitored on an ongoing basis.
At 31 December 2022, the Company had a foreign currency position of € 47,890 thousand (31 December 2021: € 47,674 thousand). They relate to direct investments in financial instruments quoted in those currencies and there is no currency hedging whatsoever.
The composition of cash and cash equivalents at credit institutions, cheques and cash on hand at 31 December 2022 and 2021 is as follows:
| 2022 | 2021 | |
|---|---|---|
| Cash at credit institutions (Note 8.1.1) | 28,061 | 98,910 |
| Cash on hand (Note 8.1.1) | 1 | 1 |
| Financial instruments maturing within 3 months | 15,978 | - |
| 44,040 | 98,911 |
Of the total balance of cash at banks at 31 December 2022 and 2021, a total of € 20,500 thousand and € 63,334 thousand, respectively, was held at Bankinter, S.A. (see Note 15).
At 31 December 2022 and 2021 a current account had been pledged to a reinsurer for a total of € 2,100 thousand to secure compliance with certain contractual obligations. The remaining amount of cash and cash equivalents is subject to no further restriction on its use and disposal.
The interest rate on the Company's current accounts is negotiated with each bank. In 2022, the current account in dollars accrued an average yield of 1.98% for 2022 (0.18% in 2021) and the current account with Bankinter began to accrue interest of 0.30% from November 2022.
The following table shows changes in 2022 and 2021 in each of the technical provisions shown in the accompanying balance sheets.
| Provision for unearned premiums |
Provision for claims (*) |
Provision for unexpired risks |
|
|---|---|---|---|
| Direct insurance | |||
| Balance at 31 December 2021 | 449,740 | 291,657 | 3,280 |
| Allowances | 470,783 | 325,029 | 2,378 |
| Amounts utilised | (449,740) | (291,657) | (3,280) |
| Balance at 31 December 2022 | 470,783 | 325,029 | 2,378 |
| Ceded and retroceded reinsurance | |||
| Balance at 31 December 2021 | 4,280 | 15,873 | - |
| Allowances | 4,554 | 14,709 | - |
| Amounts utilised | (4,280) | (15,873) | - |
| Balance at 31 December 2022 | 4,554 | 14,709 | - |
| Provision for unearned premiums |
Provision for claims (*) |
Provision for unexpired risks |
|
|---|---|---|---|
| Direct insurance | |||
| Balance at 31 December 2020 | 446,423 | 271,541 | 4,622 |
| Allowances | 449,740 | 291,657 | 3,280 |
| Amounts utilised | (446,423) | (271,541) | (4,622) |
| Balance at 31 December 2021 | 449,740 | 291,657 | 3,280 |
| Ceded and retroceded reinsurance | |||
| Balance at 31 December 2020 | 3,705 | 8,772 | - |
| Allowances | 4,280 | 15,873 | - |
| Amounts utilised | (3,705) | (8,772) | - |
| Balance at 31 December 2021 | 4,280 | 15,873 | - |
(*) At the end of 2022 and 2021, this provision included € 6,837 thousand and € 6,239 thousand, respectively, as the provision for outstanding other insurance claims, a service provided by Línea Directa Asistencia, S.L.U. (see Note 15).
The provision for unexpired risks is there to supplement the provision for unearned premiums, if the latter is not enough to cover the cost of all the risks and expenses for which the insurance company is responsible over the period of coverage that has not elapsed upon reaching the end date of the financial year. In 2022, the Company recognised a total of € 2,378 thousand for this item in the Health segment (€ 3,280 thousand in 2021).
The development of the Company's benefit provision in 2022 without the reinsured and travel assistance guarantees, corresponding only to claims outstanding as at 31 December 2021, broken down by line of business, is as follows:
| Provision at 31/12/2021 |
Net payments |
Provision at 31/12/2022 |
Surplus (Deficit) |
|
|---|---|---|---|---|
| Motor, general liability insurance | 193,587 | 105,237 | 83,656 | 4,694 |
| Motor, other coverage | 52,360 | 32,089 | 14,545 | 5,726 |
| Home | 21,252 | 15,126 | 5,112 | 1,014 |
| Health | 4,163 | 2,525 | 689 | 949 |
| Total | 271,362 | 154,977 | 104,002 | 12,383 |
Incurred but not reported (IBNR) claims are included in the provision at year-end 2022 and 2021.
The development of the Company's benefit provision in 2021 without reinsured guarantees and travel assistance, corresponding only to claims outstanding as at 31 December 2020, broken down by line of business, is as follows:
| Provision at 31.12.2020 |
Net payments |
Provision at 31/12/2021 |
Surplus (Deficit) |
|
|---|---|---|---|---|
| Motor, general liability insurance | 173,104 | 94,571 | 72,978 | 5,555 |
| Motor, other coverage | 55,828 | 25,390 | 15,493 | 14,946 |
| Home | 20,492 | 14,218 | 6,267 | 7 |
| Health | 3,223 | 1,718 | 233 | 1,273 |
| Total | 252,647 | 135,897 | 94,971 | 21,781 |
Claims incurred but not reported (IBNR) are included in the provision at the end of 2022 and 2021 for all segments, as the provision for outstanding, reported and unreported claims is calculated jointly using statistical methods.
Under the terms of the collective bargaining agreement for the industry, the Company is required to take out a collective life insurance policy for all of its employees. This policy has been externalised in the form of a risk insurance policy renewable annually. This agreement resulted in total accrued insurance premiums of € 511 thousand in 2022 (€ 289 thousand in 2021).
The undertaking is also obligated to pay a retirement bonus, though only if the employee retires at the normal age of retirement while an active employee at the undertaking. This obligation is externalised in the form of a machete policy and therefore the Company does not recognise any provision in its financial statements.
At present, only those employees hired before 1 January 2017 who have decided not to migrate to the new system provided for under the agreement remain adhered to the existing system. This agreement resulted in total accrued insurance premiums of € 13 thousand in 2022 (€ 42 thousand in 2021). The mathematical provision amounted to € 212 thousand at 31 December 2022 (€ 214 million at 31 December 2021). Policy surrenders in 2022 amounted to € 14 thousand (2021: € 10 thousand).
For employees hired on or after 1 January 2017 and those who have decided to avail themselves of the new system, the Company has externalised its obligations by arranging a defined contribution insurance policy covering more contingencies than the old system. Premiums accrued under this new policy totalled € 739 thousand during the period (€ 708 thousand in 2021), while a mathematical provision was € 5,602 thousand (€ 4,845 thousand in 2021). There were no bailouts in 2022 and 2021. The mobilisation of the rights of employees who decided to take advantage of the new system became effective in 2020.
The Company also has a collective insurance policy in effect to formalise its retirement pension commitments with certain members of Senior Management. These defined contribution policies are also externalised and regular contributions are made for the different members of the group. In 2022, this policy accrued premiums of € 626 thousand and its mathematical provision amounted to € 9,554 thousand. A surrender totalling € 1,102 thousand also took place during the period. In 2021, the policy accrued premiums of € 1,118 thousand and its mathematical provision at year-end was € 11,677 thousand. The contributions made to this policy are entirely voluntary for the Company and are made at the discretion of the Board of Directors.
The Company also has a defined contribution savings and retirement insurance policy in effect for members of Senior Management. This policy accrued premiums of € 62 thousand in 2022 and its mathematical provision at year-end came to € 664 thousand. In 2021, the policy accrued premiums of € 99 thousand and its mathematical provision at year-end was € 595 thousand.
This heading shows the estimated amount due to policyholders from the insurer of the injured party and the recoveries made by the latter upon enforcing the settlement agreements.
| Carrying amount | ||
|---|---|---|
| 2022 | 2021 | |
| Balance at the beginning of the year |
21,915 | 16,174 |
| Allowances (Note 21) | 25,338 | 21,915 |
| Amounts utilised (Note 21) | (21,915) | (16,174) |
| Balance at the end of the year | 25,338 | 21,915 |
The following changes occurred during the year:
The heading "Debts and accounts payables" breaks down as follows at 31 December 2022 and 2021:
| 2022 | 2021 | |
|---|---|---|
| Due on direct insurance business | 2,526 | 2,526 |
| Due to policyholders | 2,009 | 1,939 |
| Due to agents, brokers and intermediaries | 481 | 587 |
| Conditional claims | - | - |
| Due on reinsurance business (Note 8.1.1.2) | 1,363 | 1,244 |
| Other debts: | 14,835 | 16,694 |
| Personal income tax withholdings payable | 1,960 | 1,964 |
| VAT payable | 77 | 396 |
| Social security payable | 2,676 | 2,759 |
| Insurance Compensation Consortium payable | 1,596 | 1,496 |
| Tax payable on insurance premiums | 6,288 | 5,938 |
| Other taxes payable | 2,238 | 4,141 |
| Due to group companies and associates (Note 15) | 276 | 364 |
| Other debts | 25,713 | 139,043 |
| On goods delivered and services rendered | 21,039 | 20,054 |
| On securities lending | - | 115,306 |
| Outstanding remuneration | 4,674 | 3,683 |
| 44,677 | 159,871 |
As at 31 December 2022 and 2021, there were no debts with Ambar Medline, S.L.U (see Note 15).
Below is the breakdown of receivables with group companies:
| 2022 | 2020 | |
|---|---|---|
| Dividend payable | - | - |
| Trade payables to group companies | 252 | 340 |
| Deposit with Centro Avanzado de |
24 | 24 |
| Reparaciones, CAR, S.L.U. | ||
| Total | 276 | 364 |
As at 31 December 2021, the sub-heading "On securities lending" showed the monetary guarantee received for a public debt repo transaction (assignment of government bonds with repurchase agreement) with a total carrying amount of € 115,305 thousand, including uncollected accrued interest and comprising two repos, one for Spanish Government securities and the other for Italian Government securities that matured on 10 January 2022. The counterparty to the transactions is Banco BBVA. Guarantees on the transactions amounted to € 115,305 thousand. On 10 January 2022, the two repo transactions were renewed with the same Spanish and Italian government securities, although in November 2022 the Group ultimately agreed to settle the repo definitively.
Under the repo transactions described above, the Group retains both the risks and the rights of ownership of the asset. It therefore retains the contractual rights to receive the cash flows from the financial asset, but assumes the contractual obligation to pay the cash flows to BBVA under the terms of the agreement signed with the bank.
Therefore, the "Outstanding remuneration" sub-heading does not include any provision for the triannual bonus but does include other recurring incentives, of an annual, quarterly and monthly nature pending payment for € 4,170 thousand as at 31 December 2022 (€ 3,683 thousand at December 2021).
The following table provides the information required under Final Provision Two of Law 31/2014, of 3 December.
| 2022 Days |
2021 Days |
|
|---|---|---|
| Average supplier payment period | 20.82 | 17.94 |
| Ratio of transactions paid | 20.84 | 18.66 |
| Ratio of transactions outstanding | 20.24 | 8.82 |
| Amount (in thousand euro) |
Amount (in thousand euro) |
|
| Total payments made | 254,386 | 251,168 |
| Total payments outstanding | 6,288 | 6,722 |
(*) When a figure is shown in brackets, it means that the amount is negative, representing either a faster average payment in relation to the maximum payment period prescribed by law, or otherwise that the outstanding transactions are, on average, at a point in time prior to reaching that maximum period.
| 2022 | |
|---|---|
| Days | |
| Invoices paid within the legal limit | 9,017 |
| Percentage of total invoices | 68.64% |
| Total invoices | 13,136 |
| Amount (in thousand euro) |
|
| Monetary volume within legal limit | 208,383 |
| Percentage of total monetary value of payments to suppliers | 79.94% |
| Total monetary value of invoices | 260,674 |
The data shown in the table above on the average payment period to suppliers relate to trade payables on debts with suppliers of goods and services, excluding payments of claims in 2022 and 2021.
The term "average payment period to suppliers" means the time taken in paying, or the delay in paying, trade payables. This "average payment period to suppliers' is calculated as a ratio where the numerator is the sum of the ratio of transactions paid divided by the total amount of payments made plus the ratio of transactions outstanding divided by the total amount of payments outstanding, while the denominator is the total amount of payments made divided by the amount of payments outstanding.
The ratio of transactions paid is calculated as a ratio where the numerator is the sum of the products corresponding to the amounts paid divided by the number of days of payment (difference between the calendar days running from the end of the maximum legal payment period through to effective payment of the transaction), while denominator is the total amount of payments made.
Meanwhile, the ratio of transactions pending payment is a ratio where the numerator is the sum of the products corresponding to the amounts pending payment, divided by the number of days pending payment (difference between the calendar days running from the end of the maximum legal payment period through to the end date of the annual accounts), and the denominator is the total amount of payments pending.
In September 2022, Law 18/2022 amended Additional Provision Three, on the duty to disclose information contained in Law 15/2010, which in turn amended Law 3/2004, on measures to combat late payment in commercial transactions. This amendment states that listed companies must publish on their website, in addition to the average payment period, the monetary volume and the number of invoices paid in a period shorter than the legal maximum period, as well as the ratio of those invoices to the total number of invoices and the total monetary amount of payments made to suppliers.
The Company has several operating leases with third parties, mainly related to vehicle leasing. The total amount of expected future payments for the years 2021 and 2022 are as follows:
| 2022 | 2021 | |
|---|---|---|
| Less than a year | 1,422 | 1,334 |
| Between 1 and 5 years | 1,040 | 1,785 |
| More than 5 years | - | - |
| Total future payments | 2,462 | 3,119 |
The breakdown of the Company's equity in 2022 and 2021 and changes therein are shown in the accompanying statements of changes in equity.
On 19 March 2020, the Board of Directors of Bankinter, S.A. approved the distribution in kind of the entire share premium —amounting to 1.184 billion euros— through the delivery to its shareholders of 82.6% of the share capital of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros, with the bank retaining a non-controlling financial interest of 17.4% in the Company. The Transaction was cleared on 22 March 2021 by the European Central Bank and by the Spanish Directorate General for Insurance and Pension Funds.
Prior to the admission of the Parent's shares to trading, on 5 April the General Shareholders' Meeting approved an extraordinary dividend of € 120 million payable to Bankinter. The Management Centre attached to the Directorate General for Insurance and Pension Funds analysed the proposal to distribute the extraordinary dividend and raised no objection to its implementation as it will have no material effect on the Company's future solvency or its ability to protect the rights and interests of policyholders.
On 15 April 2021, the National Securities Market Commission ("CNMV") approved and registered the prospectus relating to the shares of the Parent Company ("Informative Prospectus") in the corresponding official registry, with registration number 11157. Following the aforementioned distribution and approval of the prospectus, the Company's shares were subsequently admitted to trading on the continuous market on 29 April 2021 (Note 1).
Following the aforementioned distribution, the Company's shares were admitted to trading on the continuous market on 29 April 2021 (see Note 1).
On 19 March 2020, the Board of Directors of Bankinter, S.A. approved the distribution in kind of the entire share premium —amounting to 1,184 million euros— through the delivery to its shareholders of 82.6% of the share capital of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros, with the bank retaining a non-controlling financial interest of 17.4% in the Company. Following the aforementioned distribution, the Company's shares were admitted to trading on the continuous market on 29 April 2021 (see Note 1).
On 18 March 2021, the Shareholders' Meeting of Línea Directa Aseguradora, S.A. resolved in a single act:
The Company went from having 2,400,000 registered shares with a nominal value of 15.63 euros to 1,088,416,840 shares with a nominal value of 0.04 euros.
| Name of shareholder |
Amount of voluntary reserve to be netted |
Shares that increase in par value |
Numbering (both inclusive) | Final par value per share |
||
|---|---|---|---|---|---|---|
| Bankinter, S.A. | 6,024,671.09 € | 1,088,416,386.00 € | 1 | to | 1,088,416,386 | 0.04 € |
| Hispamarket, S.A. | 2.51 € | 454.00 € | 1,088,416,386 | to | 1,088,416,840 | 0.04 € |
| 6,024,673.60 € | 1,088,416,840.00 € | - | to | - |
At 31 December 2022, the Parent's share capital amounted to € 43,537 thousand and was represented by 1,088,416,840 registered shares, each having a par value of € 0.04, all fully subscribed for and paid up and conferring the same rights and obligations.
The shareholders of the Parent Company holding a stake equal to or greater than 3% of the share capital as at 31 December 2022 and 2021 and considered significant shareholders according to prevailing law and regulations governing the securities market are as follows:
| 2022 | ||
|---|---|---|
| Number | ||
| of shares | % | |
| Cartival | 212,277,276 | 19.50% |
| Bankinter | 189,555,907 | 17.42% |
| Fernando Masaveu Herrero | 57,919,846 | 5.32% |
| Lazard Asset Management | 34,778,950 | 3.20% |
| 2021 | ||
| Number | ||
| of shares | % | |
| Cartival | 208,426,443 | 19.15% |
| Bankinter | 189,550,907 | 17.42% |
| Fernando Masaveu Herrero | 50,905,871 | 4.68% |
| Lazard Asset Management | 34,778,950 | 3.20% |
At 31 December 2022 and 2021, the Company had posted the minimum capital required under the Law on the Organisation and Supervision of Private Insurance to operate in authorised insurance segments.
In accordance with prevailing commercial legislation, companies that obtain profits during the financial year must allocate 10% of these profits to the legal reserve until this reaches at least 20% of share capital. The legal reserve may be used to increase share capital but only in respect of the part of the reserve that exceeds 10% of share capital already increased. Aside from this purpose, and until the legal reserve exceeds 20% of share capital, it may only be used to offset losses and provided that no other reserves are available for this purpose.
At 31 December 2022 and 2021 the balance of this reserve was above the minimum requirement.
As at 31 December 2022 and 2021, the balance of these reserves was freely available and amounted to € 141,925 thousand and € 112,192 thousand, respectively.
The equalisation reserve is a mandatory reserve prescribed by law and may only be used to cover deviations in terms of claims incurred.
As at 31 December 2022, the balance of this reserve was € 93,608 thousand, net of the tax effect (€ 107,582 thousand, net of the tax effect in 2021). In 2022, EUR 28,127 of the equalisation reserve was used due to the high number of claims incurred during the year compared to the estimated net reinsurance risk premium. In 2022, an interim reserve of EUR 7,120 thousand was posted, while in 2021 no interim reserve was posted or applied.
The equalisation reserve must be provided in each financial year for the amount of the security surcharge included in the premiums written, with the minimum limit provided for in the technical bases of the relevant insurance segments. In the case of the Company, the endowment is mandatory in the third-party liability insurance segment for motor land vehicles for 2% of the premium written in this segment until the reserve reaches at least 35% of the risk premiums for retained insurance activities.
The limit will be increased as and when necessary in accordance with the Company's own loss experience. For this purpose, the limit of the equalisation reserve within each risk or class shall be taken.
| Equalisation reserve |
Tax effect | Interim Equalisation Reserve |
|
|---|---|---|---|
| Balance at 31 December 2021 Allowances Amounts utilised |
117,552 7,120 (28,127) |
9,970 - (7,032) |
- (7,120) - |
| Balance at 31 December 2022 | 96,546 | 2,938 | (7,120) |
Changes in the equalisation reserve during the year were as follows:
| Equalisation reserve |
Tax effect | Interim Equalisation Reserve |
|
|---|---|---|---|
| Balance at 31 December 2020 Allowances Amounts utilised |
117,552 - - |
9,970 - - |
(6,964) - 6,964 |
| Balance at 31 December 2021 | 117,552 | 9,970 | - |
With regard to interim dividends: The Board of Directors, at its meetings held on 21 April 2022, 20 September 2022 and 13 December 2022, agreed to distribute interim dividends out of 2022 profits for a total amount of € 59,601 thousand. At 31 December 2022, there were no outstanding amounts.
Since 29 April 2021, the date of the IPO, on which the Company was awarded 239,678 own shares in the exchange of Bankinter shares, it has made successive acquisitions, all disclosed to the CNMV to complete the full remuneration plan. More precisely, the Parent Company acquired a total of 795,643 treasury shares in 2021, at an average price of € 1.57 per share, representing 0.11% of the total number of shares issued (see Note 20).
In November 2022, the Group offered its employees a flexible share-based remuneration plan. Under this agreement, a total of 224,000 shares were purchased at an average price of € 0.99 per share, of which 204,676 were ultimately delivered.
| Thousand euro | Cost of purchase |
Nominal value | Number of shares |
|---|---|---|---|
| Balance at 1 January 2021 | - | - | - |
| Additions | 1,247 | 32 | 795,643 |
| Balance at 31 December 2021 | 1,247 | 32 | 795,643 |
| Balance at 1 January 2021 | 1,247 | 32 | 795,643 |
| Additions | 221 | 9 | 224,000 |
| Disposals | (450) | (18) | (362,732) |
| Balance at 31 December 2022 | 1,018 | 24 | 656,911 |
Changes in treasury shares are as follows:
The breakdown of own shares at year-end 2021 and 2022 is as follows:
| Acquisition date |
Type of acquisition |
Instruments | Price | Market value (thousand euro) |
Acquisition cost (thousand euro) |
|---|---|---|---|---|---|
| 29/04/2021 | Exchange | 239,678 | 1.32 | 316 | 316 |
| 04/05/2021 | Purchase | 186,570 | 1.61 | 300 | 300 |
| 06/05/2021 | Purchase | 94,700 | 1.58 | 150 | 150 |
| 21/07/2021 | Purchase | 64,332 | 1.77 | 114 | 114 |
| 22/07/2021 | Purchase | 85,957 | 1.73 | 150 | 150 |
| 23/07/2021 | Purchase | 59,702 | 1.74 | 104 | 104 |
| 26/07/2021 | Purchase | 27,293 | 1.76 | 48 | 48 |
| 27/07/2021 | Purchase | 23,183 | 1.75 | 41 | 41 |
| 28/07/2021 | Purchase | 14,228 | 1.75 | 24 | 24 |
| 01/05/2022 | Delivery | -157,593 | 1.57 | -247 | -247 |
| 11/05/2022 | Sale | -463 | 1.26 | -1 | -1 |
| 26/05/2022 | Sale | -1 | 1.32 | 0 | 0 |
| 15/11/2022 | Purchase | 214,000 | 0.99 | 212 | 212 |
| 16/11/2022 | Purchase | 10,000 | 0.94 | 9 | 9 |
| 22/11/2022 | Delivered to employees |
-104,529 | 0.99 | -103 | -103 |
| 22/12/2022 | Delivered to employees |
-100,147 | 0.99 | -99 | -99 |
| Total | 656,911 | 1.44 | 1,018 | 1,018 |
The main item recognised off the statement of profit or loss is the valuation adjustments made to available-for-sale assets to reflect the amount of capital gains net of tax. Capital gains/(losses) net of tax came to € -30,362 thousand at 31 December 2022 (€ 43,366 thousand in net gains at 31 December 2021).
At the date of authorisation for issue of these annual accounts, the Company's directors can confirm that an internal assessment of risks and solvency has been carried out and that Línea Directa Aseguradora is compliant with overall solvency requirements based on its risk profile, approved risk tolerance limits and business strategy.
The Company has implemented proceses that are commensurate with the nature, scale and complexity of the risks inherent in its business and that enable it to properly identify and assess all existing or potential risks to which it may be exposed in the short and long run.
The directors do not expect to encounter any significant obstacles that might impede the Company's compliance with regulatory solvency and minimum capital requirements and that might affect the application of the going concern principle and the continuity of the Company's operations. The directors have yet to draw up the solvency and financial condition report for 2022. The report on the financial position and solvency of Línea Directa Aseguradora for 2022 was approved by the Board of Directors at its meeting held in March 2023.
"Related parties", in addition to the dependent and associated entities, are considered the "key personnel" of the Management of the Group (members of its Board of Directors and the Management Committee), as well as the shareholders who may directly or indirectly exercise control of the Group, as well as those or a significant influence on financial and operational decision-making as mentioned in ORDER EHA/3050/2004, of 15 September, on the information of the related transactions to be provided by companies issuing securities admitted to trading on official secondary markets.
Following the admission to listing of Línea Directa Aseguradora on 29 April 2021, the Bankinter Group and all the companies comprising that group are considered Significant Shareholders. Prior to that date, the Línea Directa Group was part of the Bankinter Group, which held a 99.99% stake. From the day of admission to trading until 30 June 2021, and as indicated in Note 14, Bankinter's percentage of participation has been reduced to 17.42%, with no representative on the Group's Board of Directors since the date of IPO.
For the purposes of a better comparison of the information with related parties, Bankinter Group companies have been considered as significant shareholders in both 2022 and 2021.
The following transactions were carried out with related parties:
| 2022 | |||
|---|---|---|---|
| Direct insurance | Premiums | Committees | Claims |
| Subsidiaries of the Company | |||
| Línea Directa Asistencia, S.L.U. | - | - | 76,229 |
| Centro Avanzado de Reparaciones CAR, S.L.U. | - | - | 11,353 |
| Ambar Medline, S.L.U. | - | 158 | - |
| LDA Reparaciones, S.L.U. | - | - | 2,812 |
| Significant shareholders | |||
| Bankinter, S.A. | 596 | 5,783 | - |
| Bankinter S.A., Sucursal en Portugal | 80 | - | - |
| Bankinter Consumer Finance, S.L.U. | 361 | 16 | - |
| Evo Banco, S.A.U | - | 110 | |
| Total at 31 December 2022 | 1,037 | 6,067 | 90,394 |
| 2021 | |||
|---|---|---|---|
| Direct insurance | Premiums | Committees | Claims |
| Subsidiaries of the Company | |||
| Línea Directa Asistencia, S.L.U. | - | - | 66,572 |
| Centro Avanzado de Reparaciones CAR, S.L.U. | - | - | 11,192 |
| Ambar Medline, S.L.U. | - | 155 | - |
| LDA Reparaciones, S.L.U. | - | - | 2,808 |
| Significant shareholders | |||
| Bankinter, S.A. | 381 | 6,017 | - |
| Bankinter S.A., Sucursal en Portugal | 67 | - | - |
| Bankinter Consumer Finance, S.L.U. | 884 | 15 | - |
| Evo Banco, S.A.U | - | 7 | |
| Total at 31 December 2021 | 1,332 | 6,194 | 80,572 |
Claims-related transactions mainly relate to vehicle inspection services arranged with subsidiary company Línea Directa Asistencia, S.L.U., as well as roadside assistance and vehicle repair services by Centro Avanzado de Reparaciones CAR, S.L.U., a company that is also wholly owned by the Company.
Commission-based transactions accrue on the sale of Company policies through Bankinter, S.A., Bankinter S.A., Sucursal en Portugal, Evo Banco, S.A. and Ámbar Medline, S.L.U, the Company's exclusive agent.
| 2022 | ||||
|---|---|---|---|---|
| Expenses Income |
||||
| Services rendered and received | Services received |
Interest and financial services |
Services rendered |
Finance income and leases |
| Subsidiaries of the Company | ||||
| Línea Directa Asistencia, S.L.U. | 2,606 | - | 173 | 16,000 |
| Moto Club LDA, S.L.U. | - | - | 3 | - |
| Centro Avanzado de Reparaciones CAR, S.L.U. | 29 | - | 57 | 125 |
| LDA Reparaciones, S.L.U. | - | - | 8 | - |
| Ambar Medline, S.L.U. | - | - | 8 | - |
| LDActivos, S.L.U. | - | - | 29 | 550 |
| Significant shareholder | ||||
| Bankinter, S.A. | 1,233 | 479 | - | 801 |
| Bankinter Consumer Finance, S.L.U. | 270 | - | 880 | - |
| Bankinter, S.A. Sucursal en Portugal | 43 | - | - | - |
| Total at 31 December 2022 | 4,181 | 479 | 1,158 | 17,476 |
| 2021 | |||||
|---|---|---|---|---|---|
| Expenses | Income | ||||
| Services rendered and received | Services received |
Interest and financial services |
Services Finance income rendered and leases |
||
| Subsidiaries of the Company | |||||
| Línea Directa Asistencia, S.L.U. | 2,754 | - | 144 | 2,500 | |
| Moto Club LDA, S.L.U. | - | - | 3 | - | |
| Centro Avanzado de Reparaciones CAR, S.L.U. | 28 | - | 1 | 109 | |
| LDA Reparaciones, S.L.U. | - | - | 1 | - | |
| Ambar Medline, S.L.U. | - | - | 8 | - | |
| LDActivos, S.L.U. | - | - | 29 | 467 | |
| Significant shareholder | |||||
| Bankinter, S.A. | 1,140 | 391 | - | 677 | |
| Bankinter Consumer Finance, S.L.U. | 318 | - | 1,573 | - | |
| Bankinter, S.A. Sucursal em Portugal | 20 | - | - | - | |
| Total at 31 December 2021 | 4,260 | 391 | 1,759 | 3,753 |
Transactions on services received from the subsidiary Línea Directa Asistencia, S.L.U. mainly relate to vehicle inspection services carried out prior to the arrangement of policies with policyholders, while financial income relates entirely to dividends charged to reserves distributed by this company (see Note 8.1.1.3).
Financial income received from LDActivos, S.L.U. is a product of the loan granted to that subsidiary by the Company, as described in Note 8.1.2) to these financial statements.
All transactions with Group companies were carried out at arm's length.
The following table shows balances with related parties at 31 December 2022 and 2021.
| Notes | Group companies |
Jointly controlled companies |
Associates | Significant shareholders |
Total | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Equity instruments | ||||||
| Holdings in group companies | 8.1.1.3 | 69,494 | - | - | - | 69,494 |
| Available-for-sale assets – Equity instruments |
8.1.1.1 | - | - | - | 10,175 | 10,175 |
| Debt securities | ||||||
| Fixed-income securities | 8.1.1.1 | - | - | - | 3,475 | 3,475 |
| Loans | 8.1.1.2 | 22,502 | - | - | 22,502 | |
| Cash and cash equivalents | 9 | - | - | - | 20,500 | 20,500 |
| Other receivables | ||||||
| Other receivables | 8.1.1.2 | 142 | - | - | 447 | 589 |
| Other assets | ||||||
| 8.1.1.1 | ||||||
| Accruals | and | 14 | - | - | 34 | 48 |
| 8.1.1.2 | ||||||
| At 31 December 2022 | 92,152 | - | - | 34,631 | 126,783 | |
| Liabilities | ||||||
| Due to agents, brokers and intermediaries |
13 | - | - | - | - | 0 |
| Dividend outstanding | 13 and 14 |
- | - | - | - | 0 |
| Due to group companies and associates |
13 | 276 | - | - | 470 | 746 |
| Provision for claims | 10 | 6,837 | - | - | - | 6,837 |
| At 31 December 2022 | 7,113 | 0 | 0 | 470 | 7,583 |
| Notes | Group companies |
Jointly controlled companies |
Associates | Significant shareholders |
Total | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Equity instruments | ||||||
| Holdings in group companies | 8.1.1.3 | 65,785 | - | - | - | 65,785 |
| Available-for-sale assets – Equity | 8.1.1.1 | - | - | - | 9,950 | 9,950 |
| instruments | ||||||
| Debt securities | ||||||
| Fixed-income securities | 8.1.1.1 | - | - | - | 4,181 | 4,181 |
| Loans | 8.1.1.2 | 22,981 | - | - | 22,981 | |
| Cash and cash equivalents | 9 | - | - | - | 63,334 | 63,334 |
| Other receivables | ||||||
| Other receivables | 8.1.1.2 | 529 | - | - | - | 529 |
| Other assets | ||||||
| 8.1.1.1 | ||||||
| Accruals | and | 4 | - | - | 34 | 38 |
| 8.1.1.2 | ||||||
| At 31 December 2021 | 89,229 | - | - | 77,499 | 166,798 | |
| Liabilities | ||||||
| Due to agents, brokers and | 13 | - | - | - | - | 0 |
| intermediaries | ||||||
| Dividend outstanding | 13 and | - | - | - | - | 0 |
| 14 | ||||||
| Due to group companies and | 13 | 388 | - | - | 791 | 1,179 |
| associates | ||||||
| Provision for claims | 10 | 6,239 | - | - | - | 6,239 |
| At 31 December 2021 | 6,627 | 0 | 0 | 791 | 7,418 |
The Company operates entirely in Spain and Portugal. With respect to Portugal, the Group was authorised to operate in the Assistance segment on 25 September 2017. As this line of activity was residual and immaterial in both 2022 and 2021, it has not been deemed relevant to break down the information by geographical area.
Following the IPO of Línea Directa Aseguradora, S.A. Compañía de Seguros y Reaseguros in April 2021, Bankinter, S.A. ceased to be the Parent for VAT purposes of the Insurance Group, comprising Línea Directa Aseguradora, S.A. Compañía de Seguros y Reaseguros, and several of its subsidiaries (Línea Directa Asistencia S.L.U., Centro Avanzado de Reparaciones, CAR, S.L.U., Ambar Medline, S.L.U. and LDA Reparaciones), leading to the departure of this Insurance Group from the VAT Group 128/09. Simultaneously and uninterruptedly, the Boards of Directors of these Companies agreed to re-qualify themselves with effective date 1 April 2021 for the Special Regime of Chapter IX of the Title of Law 37/1992 on Value Added Tax, thus forming the new VAT Group 0130/21, whose Parent Company is Línea Directa Aseguradora, S.A. Insurance and Reinsurance Company.
On 22 April 2015, Línea Directa Aseguradora, S.A. notified the tax authorities of its decision to file consolidated tax returns, as permitted under the Spanish Corporate Income Tax Law, thus forming and becoming the parent of a new consolidated tax group (Tax Consolidation Group No. 486/15) comprising the following companies:
| Tax no. | |
|---|---|
| Parent | |
| Línea Directa Aseguradora, S.A. Compañía de Seguros y | |
| Reaseguros | A80871031 |
| Subsidiaries | |
| LDActivos, S.L.U. | B86322880 |
| Línea Directa Asistencia, S.L.U. | B80136922 |
| Centro Avanzado de Reparaciones CAR, S.L.U. | B84811553 |
| Ambar Medline, S.L.U. | B85658573 |
| Moto Club LDA, S.L.U. | B83868083 |
| LDA Reparaciones, S.L.U. | B87619961 |
Law 27/2014 of 27 November, on income tax, sets, inter alia, the tax rate payable by the Group in 2022 and 2021 at 25%.
The reconciliation between accounting profit and taxable income for corporate income tax purposes in 2022 and 2021 is as follows:
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Statement of profit or loss |
Income and expenses recognised directly in equity |
Statement of profit or loss |
Income and expenses recognised directly in equity |
||
| Accounting profit/(loss) for the year | 70,681 | - | 108,115 | - | |
| Corporate income tax | 17,652 | - | 33,582 | - | |
| Permanent differences: | |||||
| - Increases | 2,108 | - | 2,768 | - | |
| - Reductions | (17,116) | - | (6,432) | - | |
| Taxable profit/(loss) | 73,325 | - | 138,032 | - | |
| Temporary differences: | |||||
| Originating in the year | |||||
| - Increases | 22,314 | 98,305 | 1,818 | 1,375 | |
| - Reductions | - | - | - | - | |
| Originating in previous years | |||||
| - Increases | 4 | - | 2 | - | |
| - Reductions | (1,600) | - | (5,893) | - | |
| Tax base | 94,043 | 98,305 | 133,959 | 1,375 |
Details of current and deferred income tax expense recognised in the statement of profit or loss for 2022 and 2021 are as follows:
| 2022 | 2021 | |
|---|---|---|
| Current tax expense | 22,754 | 32,577 |
| Adjustments to deferred taxes | (5,102) | 1,005 |
| Corporate income tax expense | 17,652 | 33,582 |
Income tax expense recognised in 2022 and 2021 was calculated on the basis of the taxable profit/(loss) shown in the above table, as follows:
| 2022 | 2021 | |
|---|---|---|
| Accounting profit/(loss) before tax | 88,333 | 141,697 |
| Tax rate | 25% | 25% |
| Tax payable | 22,083 | 35,424 |
| Deductions on tax payable | (756) | (1,072) |
| Adjustment for settlement of previous year CIS | (24) | 146 |
| Non-deductible expenses | 527 | 692 |
| Non-qualifying income | (4,279) | (1,608) |
| Other deductions and amounts utilised, net | 100 | - |
| Corporate income tax expense | 17,652 | 33,582 |
In 2021, it was decided to reverse the contingent tax liabilities recognised under the heading "Provision for taxes and other legal contingencies" of the balance sheet, which, at 31 December 2020, amounted to 492 because the Company's directors estimated that there was only a remote possibility of being fined or sanctioned as a result of the different interpretations of the tax regulations applicable to the transactions.
The permanent increases in 2022 are due to various transactions that are not deductible for corporate income tax purposes, specifically the contributions made by the company, linked to contingencies similar to pension plans, which are not tax deductible under article 14.2 of the Corporate Income Tax Act and the donations made by the company to the Línea Directa Foundation or other entities. The decreases in permanent differences in 2022 have their origin in the distribution of dividends made by Línea Directa Asistencia and the profits derived from repayments of shares for investments in companies and venture capital funds.
The amount of temporary differences arising in the year mainly consists of adjustments to provisions, which, according to Articles 13 and 14 of the Corporate Income Tax Law, are not deductible for tax purposes, as well as the application of part of the equalisation reserve. Reductions arising in prior years relate mainly to the reversal of positive adjustments to non-tax deductible provisions.
Temporary changes originating in the year include the depreciation or revaluation of investments classified as available for sale.
| 2022 | 2021 | |
|---|---|---|
| Receivable from the Tax Consolidation Group | 2,297 | 2,518 |
| Tax assets | ||
| Current tax | ||
| Corporate income tax – Tax Consolidation Group (Note 15) | 1,650 | 3,855 |
| Corporate income tax – Tax Consolidation Group 2020 (Note 15) | - | 14,381 |
| Withholdings for the year | 950 | 668 |
| Deferred tax | ||
| Temporary differences | 23,371 | 8,419 |
| Tax liabilities | ||
| Current tax | ||
| Income tax payable – Tax Consolidation Group (Note 15) | - | - |
| Deferred tax | ||
| Temporary differences | 28,006 | 44,456 |
Tax assets and liabilities were as follows the end of 2022 and 2021:
Current tax assets correspond to the amount of corporate income tax payable (receivable) for 2022 and 2021, net of payments on account and income tax withholdings for the year that will be settled in the following year.
Tax assets due to temporary differences relate to temporary differences arising in the year and the tax effect on capital losses sustained on the "available-for-sale" investment portfolio. The temporary differences existing at 31 December 2022 will be reversed from 2023 onwards. Therefore, deferred corporate income tax is calculated by applying a tax rate of 25% to the deductible temporary differences arising at the end of the year (increases) and the reversal of deductible temporary differences from the previous year (reductions).
The deferred assets include an amount of € 6,161 thousand that was registered as a result of the Corporate Tax Inspection for the years 2011 to 2013 and which refers to contingencies of a temporary nature.
At 31 December 2022 and 2021, deferred tax liabilities relate to the tax effect on:
| Originating in profit and loss |
Originating in equity | |||||
|---|---|---|---|---|---|---|
| Balance at 31.12.2021 |
Additions | Retirements | Additions | Retirements | Balance at 31.12.2022 |
|
| Deferred assets | ||||||
| Prepaid income tax | 1,453 | 327 | (477) | - | - | 1,303 |
| Capital losses on available for-sale assets |
611 | - | - | 13,380 | - | 13,911 |
| Taxes deferred | 6,161 | - | - | - | - | 6,161 |
| Rights to deductions and rebates |
94 | - | - | 74 | - | 168 |
| Deductions to be applied | - | - | - | 1,749 | - | 1,749 |
| Tax deductions and bonuses to be credited |
100 | - | - | 133 | -233 | - |
| Total | 8,419 | 327 | (477) | 15,335 | (233) | 23,371 |
| Deferred liabilities | ||||||
| Tax effect of the Equalisation Reserve |
(29,388) | - | - | - | 5,252 | (24,137) |
| Capital gains on the portfolio of available-for sale assets Liabilities – temporary |
(15,066) | - | - | - | 11,197 | (3,870) |
| differences from tax deduction for maintaining jobs |
- | - | - | - | - | - |
| Total | (44,455) | - | - | - | 16,448 | (28,006) |
The following table shows changes in deferred tax assets and liabilities in 2022:
The statute of limitations of the Company's taxes are open for the last four years.
In relation to the tax agency's last inspection (income tax for financial years 2011, 2012 and 2013), the assessments signed in protest were appealed before the Central Tax Appeals Board (TEAC) in 2019, which delivered its decision on 13 December 2022, partially upholding the Company's claim. The Company plans to lodge a contentious-administrative appeal before the Audiencia Nacional to continue appealing the part rejected by the TEAC.
Pursuant to Inspection Order 51/2016 of 14 November 2016, inspection proceedings were initiated in relation to the surcharges payable to the Insurance Compensation Consortium (CSS) in 2016. On 22 December 2017, the Parent was notified of the findings and the corresponding arguments were then lodged by the Company on 25 January. On 21 June 2018, a resolution was received from the Directorate General of Insurance and Pension Funds. On 27 May 2019, a lawsuit was filed with the High Court of Justice in Madrid. The Court's ruling was received on 23 April 2021, in which the allegations presented by the Company were partially upheld. On 9 June 2021, the Company filed an appeal in cassation before the Supreme Court for the part of the ruling that was not upheld, having been admitted for processing on 21 December 2021 and specifying that the issue does present cassational interest. On 23 September 2022, the Supreme Court ruled in favour of the Directorate's criteria.
The Board of Directors does not believe that these proceedings will ultimately result in any significant contingency, control measure or any other risks that might have a significant impact on the Company's separate annual accounts.
Technical income and expenses for 2022 and 2021 are as follows:
2022
| Total | Motor, general liability insurance |
Motor, other coverage |
Home | Other insurance |
Health | |
|---|---|---|---|---|---|---|
| I.1.1. Direct insurance | 946,679 | 356,046 | 416,741 | 143,713 | 1,097 | 29,082 |
| I.1.3. Change in provision for outstanding premiums | (26) | (20) | (13) | (6) | - | 13 |
| I.2. Premiums from ceded reinsurance | (26,139) | (1,593) | (3,153) | (8,234) | (35) | (13,124) |
| I.3. Change in the provision for unearned premiums | (20,141) | (8,140) | (6,590) | (5,673) | 3 | 259 |
| I.3.1. Direct insurance | (20,141) | (8,140) | (6,590) | (5,673) | 3 | 259 |
| I.4. Change in the provision for unearned premiums on reinsurance |
274 | - | - | - | - | 274 |
| I. Total premiums earned, net of reinsurance |
900,647 | 346,293 | 406,985 | 129,800 | 1,065 | 16,504 |
| II.1. Income from investments in property, plant and equipment |
127 | 80 | 47 | - | - | - |
| II.2. Income from financial investments | 34,702 | 16,851 | 9,897 | 5,119 | 39 | 2,796 |
| II.3. Application of value adjustments for investments | 110 | 69 | 41 | - | - | - |
| II.3.2.Investments in property, plant and equipment | - | - | - | - | - | - |
| II.3.2.Financial investments | 110 | 69 | 41 | - | - | - |
| II.4. Gains/(losses) on realisation of investments | 33,490 | 21,099 | 12,391 | - | - | - |
| II.4.1.Investments in property, plant and equipment | - | - | - | - | ||
| II.4.2.Financial investments | 33,490 | 21,099 | 12,391 | - | - | - |
| II. Total investment income | 68,429 | 38,099 | 22,376 | 5,119 | 39 | 2,796 |
| III. Other technical income | - | - | - | - | - | - |
| IV.1. Claims paid | 592,098 | 257,478 | 262,420 | 61,287 | 111 | 10,802 |
| IV.1.1. Direct insurance | 606,536 | 258,037 | 262,420 | 64,878 | 111 | 21,090 |
| IV.1.3. Reinsurers' share | (14,438) | (559) | - | (3,591) | - | (10,288) |
| IV.2. Change in the provision for claims | 34,536 | 19,635 | 6,244 | 7,947 | (101) | 811 |
| IV.2.1. Direct insurance | 33,372 | 20,697 | 6,250 | 4,934 | (101) | 1,592 |
| IV.2.3. Reinsurers' share IV.3. Claims-related expenses |
1,164 | (1,062) | (6) | 3,013 | (781) | |
| IV. Total claims incurred in the period, net of | 57,881 | 34,319 | 8,050 | 12,804 | - | 2,708 |
| reinsurance | 684,515 | 311,432 | 276,714 | 82,038 | 10 | 14,321 |
| V. Changes in technical provisions | - | - | - | - | - | - |
| VI. Profit sharing | 637 | - | - | - | 637 | - |
| VII.1. Acquisition expenses | 180,012 | 60,427 | 70,936 | 36,121 | 54 | 12,474 |
| VII.2. Administration expenses | 25,632 | 6,160 | 12,506 | 5,869 | 11 | 1,086 |
| VII.3. Reinsurance commissions and profit sharing | (4,232) | - | - | - | - | (4,232) |
| VII. Total net operating expenses | 201,412 | 66,587 | 83,442 | 41,990 | 65 | 9,328 |
| VIII. Change in equalisation provision | - | - | - | - | - | - |
| IX.1. Change in provision for insolvencies | - | - | - | - | - | - |
| IX.3. Change in provision for payments under claims | (22,750) | (23,380) | 630 | - | - | - |
| settlement agreements | ||||||
| IX.4. Other technical expenses IX. Other technical expenses |
5,729 | 1,731 | 3,514 | 241 | - | 243 |
| X.I. Investment management expenses | (17,021) 5.053 |
(21,649) 3,183 |
4,144 1,870 |
241 - |
- - |
243 - |
| X.1.1.Expenses from managing investments in | - | - | - | |||
| property, plant and equipment | 2,062 | 1,299 | 763 | |||
| X.1.2. Expenses from managing financial investments | 2,991 | 1,884 | 1,107 | - | - | - |
| X.2. Investment valuation adjustments | 28 | 18 | 10 | - | - | - |
| X.2.1. Depreciation of investments in property, plant | 28 | 18 | 10 | - | - | - |
| and equipment | ||||||
| X.2.2. Impairment of investments in property, plant and equipment |
- | - | - | - | - | - |
| X.2.3. From provisions for financial investments | - | - | - | - | - | - |
| X.3. Losses on investments | 26,307 | 16,573 | 9,734 | - | - | - |
| X.3.1. Losses on investments in property, plant and | - | - | - | |||
| equipment | - | - | - | |||
| X.3.2. Losses on financial investments | 26,307 | 16,573 | 9,734 | - | - | - |
| X. Total investment expenses | 31,388 | 19,774 | 11,614 | - | - | - |
| Result of the non-life insurance technical account (I+II+III-IV-V-VI-VII-VIII-IX-X) |
68,145 | 8,248 | 53,447 | 10,650 | 392 | (4,592) |
2021
| Total | Motor, general liability insurance |
Motor, other coverage |
Home | Other insurance |
Health | |
|---|---|---|---|---|---|---|
| I.1.1. Direct insurance | 907,189 | 341,746 | 406,354 | 131,243 | 1,397 | 26,449 |
| I.1.3. Change in provision for outstanding premiums | 331 | 220 | 92 | (7) | - | 26 |
| I.2. Premiums from ceded reinsurance I.3. Change in the provision for unearned premiums |
(23,392) (1,975) |
(1,457) 3,229 |
(3,266) 374 |
(6,707) (5,462) |
(41) 32 |
(11,921) (148) |
| I.3.1. Direct insurance | (1,975) | 3,229 | 374 | (5,462) | 32 | (148) |
| I.4. Change in the provision for unearned premiums on | - | - | - | |||
| reinsurance | 575 | - | 575 | |||
| II. Total premiums earned, net of reinsurance | 882,728 | 343,738 | 403,554 | 119,067 | 1,388 | 14,981 |
| II.1. Income from investments in property, plant and equipment |
164 | 103 | 61 | - | - | - |
| II.2. Income from financial investments | 31,918 | 15,677 | 9,263 | 4,511 | 51 | 2,416 |
| II.3. Application of value adjustments for investments | 167 | 105 | 62 | - | - | - |
| II.3.2.Investments in property, plant and equipment | - | - | - | - | - | - |
| II.3.2.Financial investments | 167 | 105 | 62 | - | - | - |
| II.4. Gains/(losses) on realisation of investments | 22,153 | 13,925 | 8,228 | - | - | - |
| II.4.1.Investments in property, plant and equipment | 21 | 13 | 8 | - | - | - |
| II.4.2.Financial investments | 22,132 | 13,912 | 8,220 | - | - | - |
| II. Total investment income | 54,402 | 29,810 | 17,614 | 4,511 | 51 | 2,416 |
| III. Other technical income | - | - | - | - | - | - |
| IV.1. Claims paid | 533,002 | 237,448 | 228,806 | 56,871 | 64 | 9,813 |
| IV.1.1. Direct insurance | 542,962 | 237,412 | 228,806 | 57,528 | 64 | 19,152 |
| IV.1.3. Reinsurers' share | (9,960) | 36 | - | (657) | - | (9,339) |
| IV.2. Change in the provision for claims | 13,015 | 5,611 | 7,896 | (1,055) | (64) | 627 |
| IV.2.1. Direct insurance | 20,116 | 9,622 | 7,839 | 1,402 | (81) | 1,334 |
| IV.2.3. Reinsurers' share | (7,101) | (4,011) | 57 | (2,457) | 17 | (707) |
| IV.3. Claims-related expenses IV. Total claims incurred in the period, net of |
54,442 | 33,861 | 7,660 | 10,410 | - | 2,511 |
| reinsurance | 600,459 | 276,920 | 244,362 | 66,226 | - | 12,951 |
| V. Changes in technical provisions | - | - | - | - | - | - |
| VI. Profit sharing | 594 | - | - | - | 594 | - |
| VII.1. Acquisition expenses | 181,770 | 61,599 | 72,635 | 34,368 | 98 | 13,070 |
| VII.2. Administration expenses | 26,167 | 7,137 | 12,394 | 5,521 | 14 | 1,101 |
| VII.3. Reinsurance commissions and profit sharing | (5,024) | - | - | - | - | (5,024) |
| VII. Total net operating expenses | 202,913 | 68,736 | 85,029 | 39,889 | 112 | 9,147 |
| VIII. Change in equalisation provision | - | - | - | - | - | - |
| IX.1. Change in provision for insolvencies | - | - | - | - | - | - |
| IX.3. Change in provision for payments under claims | (24,489) | (25,344) | 855 | - | - | - |
| settlement agreements | ||||||
| IX.4. Other technical expenses | 1,711 | 590 | 1,023 | 5 | - | 93 |
| IX. Other technical expenses X.I. Investment management expenses |
(22,778) 6,444 |
(24,754) 4,051 |
1,878 2,393 |
5 - |
- - |
93 - |
| X.1.1.Expenses from managing investments in | - | - | - | |||
| property, plant and equipment | 1,961 | 1,233 | 728 | |||
| X.1.2. Expenses from managing financial investments | 4,483 | 2,818 | 1,665 | - | - | - |
| X.2. Investment valuation adjustments | 28 | 18 | 10 | - | - | - |
| X.2.1. Depreciation of investments in property, plant | - | - | - | |||
| and equipment | 28 | 18 | 10 | |||
| X.2.2. Impairment of investments in property, plant and equipment |
- | - | - | - | - | - |
| X.2.3. From provisions for financial investments | - | - | - | - | - | - |
| X.3. Losses on investments | 15,424 | 9,695 | 5,729 | - | - | - |
| X.3.1. Losses on investments in property, plant and | - | - | - | |||
| equipment | 7 | 4 | 3 | |||
| X.3.2. Losses on financial investments | 15,417 | 9,691 | 5,726 | - | - | - |
| X. Total investment expenses | 21,896 | 13,764 | 8,132 | - | - | - |
| Result of the non-life insurance technical account (I+II+III-IV-V-VI-VII-VIII-IX-X) |
134,046 | 38,882 | 81,767 | 17,458 | 733 | (4,794) |
Technical results by year of occurrence for non-life segments for the years ended 31 December 2022 and 2021 are as follows:
| Motor | Home | Health | ||
|---|---|---|---|---|
| I. | Premiums earned (Direct) | 767,514 | 139,879 | 28,675 |
| Premiums net of cancellations | 782,277 | 145,558 | 29,305 | |
| +/- Change in provisions for unearned premiums | (14,730) | (5,673) | (643) | |
| +/- Change in provisions for outstanding premiums | (33) | (6) | 13 | |
| II. | Premiums from ceded reinsurance | 4,745 | 8,234 | 12,850 |
| Premiums net of cancellations | 4,745 | 8,234 | 13,124 | |
| +/- Change in provisions for unearned premiums | - | - | (274) | |
| A. Total premiums earned, net of reinsurance (I-II) | 762,769 | 131,645 | 15,825 | |
| III. | Claims incurred (Direct) | 649,343 | 82,647 | 25,460 |
| Benefits and expenses paid for claims incurred during the year, including attributable claims-related expenses |
648,635 | 81,657 | 25,527 | |
| Technical provisions for claims incurred during the year | 708 | 990 | (67) | |
| IV. | Claims incurred from reinsurance (ceded) | 2,061 | 386 | 11,104 |
| Benefits and expenses paid on claims incurred during the year |
2,061 | 386 | 11,137 | |
| Technical provisions for claims incurred during the year | - | - | (33) | |
| B. Total net reinsurance claims incurred (III-IV) | 647,282 | 82,261 | 14,356 | |
| V. | Acquisition costs | 131,363 | 36,121 | 12,474 |
| VI. | Administration expenses | 18,666 | 5,869 | 1,086 |
| VII. | Other technical expenses and income | (17,503) | 241 | 243 |
| VIII. | Commissions on ceded reinsurance | - | - | (4,232) |
| IX. | Technical financial income net of the same expenses | 29,086 | 5,119 | 2,796 |
| Profit/(loss) | 12,050 | 12,272 | (5,306) |
| Motor | Home | Health | ||
|---|---|---|---|---|
| X. | Premiums earned (Direct) | 761,668 | 127,603 | 25,146 |
| Premiums net of cancellations | 757,753 | 133,072 | 26,610 | |
| +/- Change in provisions for unearned premiums | 3,603 | (5,462) | (1,490) | |
| +/- Change in provisions for outstanding premiums | 312 | (7) | 26 | |
| XI. | Premiums from ceded reinsurance | 4,722 | 6,707 | 11,346 |
| Premiums net of cancellations | 4,722 | 6,707 | 11,921 | |
| +/- Change in provisions for unearned premiums | - | - | (575) | |
| A. Total premiums earned, net of reinsurance (I-II) | 756,946 | 120,896 | 13,800 | |
| XII. | Claims incurred (Direct) | 586,931 | 69,206 | 23,199 |
| Benefits and expenses paid for claims incurred during the year, including attributable claims-related expenses |
586,099 | 68,709 | 22,805 | |
| Technical provisions for claims incurred during the year | 832 | 497 | 394 | |
| XIII. | Claims incurred from reinsurance (ceded) | 3,787 | 2,813 | 10,148 |
| Benefits and expenses paid on claims incurred during the year |
3,787 | 2,813 | 9,951 | |
| Technical provisions for claims incurred during the year | - | - | 197 | |
| B. Total net reinsurance claims incurred (III-IV) | 583,144 | 66,393 | 13,051 | |
| XIV. | Acquisition costs | 134,233 | 34,368 | 13,070 |
| XV. | Administration expenses | 19,531 | 5,521 | 1,101 |
| XVI. | Other technical expenses and income | (22,837) | 5 | 93 |
| XVII. | Commissions on ceded reinsurance | - | - | (5,024) |
| XVIII. Technical financial income net of the same expenses | 25,528 | 4,511 | 2,416 | |
| Profit/(loss) | 68,403 | 19,120 | (6,075) |
In the Health segment, a provision of € 2,378 thousand was posted in 2022 to cover unexpired risks (€ 3,280 thousand in 2021) (see Note 10).
In the other insurance segment, claims are settled at time of occurrence and there are no claims incurred arising from previous periods. Therefore, there is no difference between the technical account, which shows a positive result, and the account by time of occurrence, meaning it is not necessary to assign a provision for unexpired risks.
The remuneration accrued by the Company's directors and Senior Management in 2022 amounted to € 1,103 thousand and € 3,957 thousand, respectively (€ 1,133 thousand and € 3,029 thousand, respectively, in 2021), as follows:
| 2022 | Fixed salary | Variable salary |
Remuneratio n in kind |
Per diems/allowanc es |
Consolidate d social security |
Total |
|---|---|---|---|---|---|---|
| Senior Management |
3,371 | 380 | 187 | - | 58 | 3,996 |
| Directors | 830 | 22 | 31 | 221 | - | 1,104 |
| Total | 4,201 | 353 | 218 | 221 | 58 | 5,100 |
| 2021 | Fixed salary | Variable salary |
Remuneratio n in kind |
Per diems/allowance s |
Consolidate d social security |
Total |
|---|---|---|---|---|---|---|
| Senior Management |
2,191 | 417 | 177 | - | 63 | 2,848 |
| Directors | 816 | 74 | 26 | 209 | 8 | 1,133 |
| Total | 3,007 | 491 | 203 | 209 | 71 | 3,981 |
Senior Management comprises the Group's Management Team, without counting the current CEO and the former Chairman, who are named as directors, along with their fellow directors.
The Directors section includes the remuneration of the members of the Board of Directors in their capacity as such and for their executive functions. Remuneration for executive functions includes, in particular, that paid to the former Chief Executive Officer for the period running from 1 January 2022 to 17 February 2022, as well as the remuneration paid to the current Chief Executive Officer for her current functions as of 17 February 2022. The table does not include the remuneration received by the former Chief Executive Officer upon leaving the Company, who in 2022 received € 405 thousand for this item, with a total of € 270 thousand outstanding over the following three years.
The "Fixed salary" item of Senior Management includes the amounts accrued for the departure of members of the Management Committee, in accordance with prevailing law and regulations.
The item "Variable salary" does not include amounts accrued during the year that are to be deferred to future years and which are subject to malus and clawback clauses. In 2022, the variable salary to be deferred over the next three financial years amounted to € 127 thousand for Senior Management. In the case of the Chief Executive Officer, the portion shown in the table relates to the non-deferred accrued portion of their salary, having accrued another portion in shares. The amount to be deferred over the following three years amounts to € 29 thousand, half of which will be received in cash and the other half in kind. The variable salary not included in the table above for 2021 that is deferred over the following three years amounts to € 278 thousand for Senior Management and € 39 thousand for the directors.
The heading "Allowances" shows, in 2022 and 2021, the amounts received by all individuals that held the position of Board member during the year, including the € 26 thousand received by two directors who stood down following the filing of the IPO prospectus with the CNMV.
The item "Consolidated social security" includes a defined contribution savings and retirement scheme in the form of a savings policy for the Group's Senior Management. The savings policy for the Group's Senior Management accrued € 58 thousand in 2022 and its mathematical provision at year-end came to € 664 thousand. In 2021, it accrued premiums of 63 million euros and its mathematical provision at year-end was 595 million euros. These premiums do not include any voluntary contributions made by the executives.
The Group also has a collective insurance policy in effect to formalise its retirement pension commitments with certain members of Senior Management and the CEO. These defined contribution policies are also externalised and regular contributions are made for the different members of the group (Note 21). In 2022, this policy generated premium payments of € 591 thousand (€ 1,118 thousand in 2021) and € 1,102 thousand was surrendered, while in 2021 there were no surrenders. The mathematical provision for pensions for members of Senior Management amounted to € 9,246 thousand at 31 December 2022 (€ 11,677 thousand in 2021). The contributions made are not shown in the table above because they are nonvested remuneration, since there are events and circumstances that may entail their non-payment in the future.
In 2022 and 2021, the Group paid € 55 thousand in D&O insurance premiums for members of Senior Management and other executives with decision-making powers at the Group.
At 31 December 2022 and 2021, no advances or loans had been granted by the Parent to the members of its Board of Directors or Senior Management and no obligations had been assumed on their behalf as way of guarantee or collateral.
Expenses shown on the technical account for 2022 and 2021 are as follows:
| 2022 | 2021 | |
|---|---|---|
| Change in provision for payments under settlement agreements (Note 12) |
3,423 | 5.741 |
| Change in certain recoveries due to settlement agreements | (2,531) | (7.448) |
| Payments and recoveries under claim settlement agreements |
(23,642) | (22.782) |
| Expenses recognised at destination | 5,729 | 1.711 |
| Total other technical expenses | (17,021) | (22.778) |
Other income and other expenses on the non-technical accounts are as follows:
| 2022 | 2021 | |
|---|---|---|
| Costs of sending documentation to customers | 43 | 247 |
| Costs of distributing policies of other insurers | - | 143 |
| Total Other non-technical expenses | 43 | 390 |
| Intermediation income from credit cards and other insurers' policies |
547 | 613 |
| Commission payment for Insurance Compensation Consortium |
629 | 596 |
| Income from bank branch management | 1,069 | 868 |
| Income from management expenses passed on | 622 | 230 |
| Income from profit sharing in businesses delivered to Bankinter |
450 | 957 |
| Other sundry income | 914 | 2,277 |
| Total Other non-technical income | 4,231 | 5,541 |
Guarantees provided to third parties amounted to € 1,874 thousand at 31 December 2022, mainly in the form of guarantees for investments in advertising (€ 1,874 thousand at 31 December 2021), and € 701 thousand in the form of court guarantees and deposits due on legal claims (€ 362 thousand at 31 December 2021).
The breakdown of staff expenses in 2022 and 2021 is as follows:
| 2022 | 2021 | |
|---|---|---|
| Wages and salaries | 80,799 | 75,815 |
| Termination benefits | 4,921 | 1,574 |
| Other staff expenses | 22,171 | 25,904 |
| 107,891 | 103,293 |
The average number of employees on the payroll in 2022 and 2021, broken down by occupational category, is as follows:
| 2022 | 2021 | |||||
|---|---|---|---|---|---|---|
| Total | Female | Male | Total | Female | Male | |
| Managers | 66 | 35 | 31 | 64 | 34 | 30 |
| Expert professionals | 345 | 165 | 180 | 343 | 168 | 175 |
| Professionals | 636 | 387 | 249 | 635 | 385 | 250 |
| Staff | 1,151 | 751 | 400 | 1,187 | 767 | 420 |
| Total | 2,198 | 1,338 | 860 | 2,229 | 1,354 | 875 |
Meanwhile, the distribution by gender of the Company's employees and directors, broken down by category and gender, was as follows at 31 December 2022 and 2021:
| 2022 | 2021 | |||||
|---|---|---|---|---|---|---|
| Total | Female | Male | Total | Female | Male | |
| Directors | 7 | 4 | 3 | 6 | 3 | 3 |
| Managers | 69 | 36 | 33 | 64 | 34 | 30 |
| Expert professionals | 340 | 163 | 177 | 347 | 168 | 179 |
| Professionals | 619 | 379 | 240 | 643 | 388 | 255 |
| Staff | 1,134 | 734 | 400 | 1,173 | 762 | 411 |
| Total | 2,169 | 1,316 | 853 | 2,233 | 1,355 | 875 |
The average number of employees with a degree of disability greater than or equal to 33% is 33 (34 employees in 2021).
The Company's Chief Executive Officer and members of the Management Committee are included in an extraordinary remuneration plan of the Group, consisting of the delivery of shares over the three years following the IPO. The purpose of this Plan, which was approved at the General Shareholders' Meeting held on 18 March 2021, is to offer the subjects the possibility of receiving a certain number of shares in the three years following the date of IPO. Of the 13 participants in the Remuneration Plan, 12 are employees of the Company, while one of them is employed by another Group company, namely Línea Directa Asistencia. The main features of the plan are as follows:
The cost of the programme to the Company is recorded as a personnel expense and is offset by a reserve for treasury shares in equity in the balance sheet, which will be cancelled on the three anniversaries when the shares are delivered to the employees.
At 31 December 2021 and 2022, the staff expense accrued and recognised at the Company amounted to € 956 thousand. This allocation was made on the assumption that all plan members would meet the tenure condition on each anniversary.
The value of the incentive to be received in shares of the Company is assessed on the basis of the fair value of the equity instruments allocated at the grant date, considering the terms and conditions of the Plan. The number of equity instruments included when determining the amount of the transaction is adjusted each year through to the vesting date.
The Company had 637,586 treasury shares at 31 December 2022 with which to honour the Group's remuneration plan. Since 29 April 2021, the date of the IPO, on which the Company was awarded 239,678 own shares in the exchange of Bankinter shares, it has made successive acquisitions, all disclosed to the CNMV to complete the complete remuneration plan. The average purchase price of these shares was € 1.57 per share. Some shares were delivered in 2022, while the rest remain in equity. Details of treasury shares corresponding to the remuneration plan are as follows:
| Acquisition date | Type of acquisition |
Instruments | Price | Market value (thousand euro) |
Acquisition cost (thousand euro) |
|---|---|---|---|---|---|
| 29/04/2021 | Exchange | 239,678 | 1.32 | 316 | 316 |
| 04/05/2021 | Purchase | 186,570 | 1.61 | 300 | 300 |
| 06/05/2021 | Purchase | 94,700 | 1.58 | 150 | 150 |
| 21/07/2021 | Purchase | 64,332 | 1.77 | 114 | 114 |
| 22/07/2021 | Purchase | 85,957 | 1.73 | 150 | 150 |
| 23/07/2021 | Purchase | 59,702 | 1.74 | 104 | 104 |
| 26/07/2021 | Purchase | 27,293 | 1.76 | 48 | 48 |
| 27/07/2021 | Purchase | 23,183 | 1.75 | 41 | 41 |
| 28/07/2021 | Purchase | 14,228 | 1.75 | 24 | 24 |
| 01/05/2022 | Delivery | -157,593 | 1.57 | -247 | -247 |
| 11/05/2022 | Sale | -463 | 1.26 | -1 | -1 |
| 26/05/2022 | Sale | -1 | 1.32 | 0 | 0 |
| Total | 637,586 | 1.60 | 998 | 998 |
The Company will deliver the corresponding shares to the employee of the subsidiary Línea Directa Asistencia on the three anniversaries, with the cost being borne by the subsidiary and the Entity receiving cash as consideration for the fair value of the shares delivered.
At the end of 2022, employees were offered the opportunity to participate in a share purchase plan as part of their flexible remuneration, which was aimed at all employees of the Company with at least six months' tenure at the Company, excluding members of the Board of Directors.
It was a one-off programme lasting two months (November and December 2022) aimed at facilitating the acquisition of Línea Directa shares among employees through a flexible remuneration programme subject to a beneficial tax regime. The conditions for being able to include the plan in the flexible remuneration programme were as follows: the amount to be allocated would be capped at € 12,000 per year, the shares must be held for three years, and the delivery may not exceed the upper limit for overall remuneration in kind of 30% of the total remuneration, nor may the minimum wage be affected in any way.
The Plan was launched at a 5% discount on the share price. The Plan was approved by the Board of Directors in September and October 2022, following a report by the Appointments, Remuneration and Corporate Governance Committee.
Changes in treasury shares under the employee share ownership plan are as follows:
| Acquisition date |
Type of acquisition | Instruments | Price | Market value (thousand euro) |
Acquisition cost (thousand euro) |
|---|---|---|---|---|---|
| 15/11/2022 | Acquisition under the employee programme |
214,000 | 0.99 | 211 | 211 |
| 16/11/2022 | Acquisition under the employee programme |
10,000 | 0.94 | 9 | 9 |
| 22/11/2022 | Delivered to employees | -104,529 | 0.96 | -100 | -100 |
| 22/12/2022 | Delivered to employees | -100,147 | 1.00 | -100 | -100 |
| Total | 19,324 | 1.07 | 20 | 20 |
The following is a breakdown of the audit fees and other services provided by PricewaterhouseCoopers Auditores, S.L. during the year for the consolidated and separate financial statements of the consolidated companies (fees excluding expenses and VAT):
| 2022 | 2021 | |
|---|---|---|
| Audit services* | 241 | 250 |
| Other services required by law | 111 | 100 |
| Other attest services | 45 | 43 |
| Total audit and related services | 397 | 393 |
| Total professional services | 397 | 393 |
*The amount of audit services accrued refers to the audit fees for the annual financial statements of the entire Línea Directa Group.
The heading "Other services required by law" mainly shows the fees for the review of the report on the financial position and solvency of the Group and its subsidiaries, as well as for the independent external attest service under limited assurance of the Non-Financial Statement (NFS).
The main items included under "Other attest services" relate to the issuance of the agreed-upon procedures report on the Group's Internal Control over Financial Reporting (ICFR) system, the limited review of the condensed consolidated interim financial statements for the year and limited reviews of the Group's subsidiaries.
At 31 December 2022 and 2021, the Company was the head of the Línea Directa Aseguradora Group, whose subsidiaries are as follows:
| Subsidiaries | Activity | Stake |
|---|---|---|
| Línea Directa Asistencia, S.L.U. | Vehicle inspections and roadside assistance |
100% |
| Moto Club LDA, S.L.U. | Sundry services related to motorcycles |
100% |
| Centro Avanzado de Reparaciones CAR, S.L.U. |
Provision of vehicle repair services | 100% |
| Ambar Medline, S.L.U. | Insurance brokerage | 100% |
| LDActivos, S.L.U. | Asset management | 100% |
| LDA Reparaciones, S.L.U. | Repair of home insurance claims | 100% |
In turn, Línea Directa Aseguradora S.A., Compañía de Seguros y Reaseguros, was part of the Bankinter Group and was consolidated commercially by global integration until the company's IPO on 29 April 2021.
On 17 July 2014, Fundación Línea Directa was founded through a nonrefundable donation to the foundation's endowment fund. The Foundation strives to improve road safety by preventing and reducing road accidents, promoting responsible behaviour at the wheel, fostering education in road safety, getting involved in post-accident prevention, intervention and care activities for victims, while also carrying out whatever other actions may be conducive to the best achievement of its goals.
The Company did not make any investments or incur any expenses in relation to environmental protection activities in 2022 and 2021.
The Company's directors consider that no significant contingencies exist when it comes to the environmental protection and improvement and do not consider it necessary to post any provision for environmental risks and expenses at 31 December 2022.
No amount has been allocated to these items, nor was there any changes in expenses or provisions in 2022, and nor were any forward contracts signed or grants received in relation to greenhouse gas emission allowances.
At the end of 2022 and 2021, none of the Company's directors, nor any person related to them within the meaning of Article 229 of the Capital Companies Law (Ley de Sociedades de Capital), notified the other directors of any conflict they may have, either directly or indirectly, with the Company's own interests.
The Customer Service Department operates in compliance with Order ECO 734/2004, of 11 March, on customer care departments and services of financial institutions, which seeks to regulate the requirements all such departments and services must meet.
The aim of the Customer Service Department (CCS) and the Consumer Ombudsman is to address and resolve any complaints or claims that any individual or legal entity may submit to the Company, guided by the principles of impartiality, speed, economy, publicity, due process and efficiency, and acting with total autonomy in respect of the Company's other departments with regard to the criteria and guidelines to be applied in discharging its functions so as to ensure fully independent decision-making.
In 2022, a total of 5,809 incidents were handled (6,207 incidents in 2021), 398 (6.85%) of which qualified as complaints (374 (6.03%) complaints in 2021) and 5,411 (93.15%) as claims (5,833 (93.97%) claims in 2021). Of the total, 20.86% related to Policy quoting and management, 69.48% to Accident management and 3.10% to the Roadside assistance service (2021: 23.23%, 68.52% and 2.66%, respectively).
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Number | % of total | Number | % of total | ||
| Complaints | 398 | 7% | 374 | 6% | |
| Claims | 5,411 | 93% | 5,833 | 94% | |
| Total cases handled | 5,809 | 100% | 6,207 | 100% |
The breakdown by type of case managed by the Group in 2022 and 2021 is as follows:
The breakdown by department of the cases generated by the Group in 2022 and 2021 is as follows:
| 2022 | 2020 | ||||
|---|---|---|---|---|---|
| Number | % of total | Number | % of total | ||
| Quotations and Policy Management |
1,212 | 21% | 1,442 | 23% | |
| Accident management | 4,036 | 69% | 4,253 | 68% | |
| Roadside assistance service | 180 | 3% | 165 | 3% | |
| Other | 381 | 7% | 347 | 6% | |
| Total cases handled | 5,809 | 100% | 6,207 | 100% |
Main issues raised by customers:
Of the total complaints and claims received in 2022, 82.10% (73% in 2021) have been considered estimated and 38.13% valid (35.28% in 2021).
In 2022, a total of 428 cases were heard by the Consumer Ombudsman (801 cases in 2021). A decision was handed down against the insured claimants in 32.94% of these cases, which relate to the following main grievances:
The percentage of decisions delivered in favour of policyholders was up on the previous year, as 67.06% of decisions went with the policyholder in 2022, while in 2021 this figure was 41.82%.
In his report, the Consumer Ombudsman calls for prompter handling of claims so that, between LINEA DIRECTA and the Consumer Ombudsman, they can be resolved ahead of the maximum deadlines prescribed by applicable law and regulations on consumer affairs, pursuant to Royal Legislative Decree 1/2007, of 16 November. It also suggests that the general terms and conditions of the policies, containing their delimitation of risks, exclusions and limitation of liability clauses, should be signed at the same time as the special terms and conditions, whether the product is arranged remotely or via traditional channels.
Insurance business risk attaches mainly to non-life insurance contracts, which in turn consists of premium sub-risk (risk of sufficiency of premiums) and reserve sub-risk (risk of sufficiency of technical provisions).
The Company manages reinsurance as a primary tool for mitigating the premium and reserve sub-risks. Reinsurance also forms part of counterparty risk due to the risk of default of the amounts recoverable from the reinsurance companies.
The reinsurance system used by the Group is based mainly on an Excess of Loss (XL) structure for each segment, so as to achieve protection against serious losses or catastrophic losses and events caused by natural phenomena not covered by the Insurance Compensation Consortium, using reinsurance to provide stability against this type of random natural catastrophes, for both occurrence and amount, and a quota share reinsurance contract for the health insurance segment signed in 2017.
On 1 September 2017, the Company entered into a quota share reinsurance contract for the health insurance business, which expires on 31 December 2029 and comes with a two-year renewal option. This contract includes an assignment of 50% of the premium income and claims cost of most of the policies of the Health segment.
The contract also includes a table of fixed and variable reinsurance commissions payable to the Company. The fixed commission is calculated as a percentage of the premium ceded and as a fixed amount until 2022. The variable commission is calculated on the basis of the premiums assigned during the term of the contract of the year, and the performance of the claims ratio during the agreed years from 2022 onward. These commissions are capped.
It also envisions profit sharing at the Company if positive technical results are obtained.
In the case of the early termination, compensation will be paid due to cancellation by any of the parties if they are unable to reach an agreement or in any other situation that frustrates the continuation and normal performance of the contract. However, early termination clauses that may pose a threat to the effective transfer of risks and rewards relate in all cases to extremely remote situations.
The performance of the technical result and the credit recognised by the Company will depend on the changes in the main technical aggregates, such as premiums, claims incurred, and acquisition and administrative expenses. There may therefore be differences in respect of the business plan defined by the Group.
Reinsurers must be filed with the National Financial Services Commission, CNSF (Comisión Nacional de Servicios Financieros) and comply with strict security requirements. They must also possess outstanding ratings that demonstrate their financial solvency. Foreign entities must present a certificate of residence in Spain.
The criteria followed for establishing the reinsurance network requires at least an 'A' rating of reinsurance companies. However, a deposit clause will be included in contracts of reinsurance companies with an S&P of rating below AA-. Any exception is approved by the Board of Directors.
The ratings of the various entities that are included in the reinsurance network are reviewed on a quarterly basis, with monitoring of the credit risk ratings published by Standard & Poor's, to control any changes in probability of default of the commitments undertaken.
The Technical Department of Línea Directa Aseguradora adjusts products and prices in accordance with the Company's general strategy. All these modifications are supported by actuarial analyses documented in the related technical notes and approved by the Technical Committee, which is the body responsible for managing this sub-risk. The Health segment is monitored by the Health Technical Area.
The Technical Committee takes operational decisions that affect prices and risk underwriting terms for the products offered by Línea Directa Aseguradora, ensuring that they are consistent with the strategy and objectives established by the Board of Directors. To do so, it considers the proposals presented by the Technical Department, also taking into account data on the position of the business and the outlook provided by the different business areas.
On 29 December 2021, the General Directorate of Insurance and Pension Funds sent a resolution of the application file for a change in the statistical methodology used in the automotive sector, in which it authorises Línea Directa Aseguradora to calculate the technical provisions of benefits in the motor sector using the Merz & Wüthrich stochastic methodology, and the deterministic methodology of average cost as a contrast methodology. The methodological change was first applied at year-end 2021 and has not had a significant impact compared to the previous methodology.
To estimate the provision for claims in the home, other insurance, health and medical assistance segments, the Company analyses each claim on its merits.
The Claims and Reserves Committee is responsible for managing the Company's reserve risk and reinsurance credit risk. It functions are to monitor the Company's reserves and provisions to ensure adequate coverage of claims, and to approve changes in the policies for the opening and provisioning of claims for all the different levels of coverage and guarantee, thus ensuring the adequacy of reserves, in accordance with the guidelines approved by the Company's Board of Directors.
Furthermore, to ensure that the Company complies with the obligations arising from Additional Provision 18 of Law 20/2015 of 14 July, and so that the technical provisions reflect the obligations arising from the contracts underwritten, the controls listed below have been put in place to post the provision for claims:
The Company's insurance business is mainly located in Spain, with no particularly significant concentration in any given geographical area.
The following table shows the premium concentration for those autonomous communities of Spain with a concentration of above 5% for 2022 and 2021:
| 2022 | 2021 | |
|---|---|---|
| Andalusia | 23.2% | 23.2% |
| Catalonia | 20.8% | 20.9% |
| Madrid | 12.7% | 12.3% |
| Valencian Community | 12.2% | 12.3% |
| Murcia | 4.8% | 4.8% |
| Other | 26.3% | 26.6% |
| Total | 100% | 100% |
The Company's business focuses on non-life segments (mainly motor risks), which, in terms of insurance premiums, show the following distribution:
| 2022 | |||||
|---|---|---|---|---|---|
| Total | Risks – Motor |
Home Risks | Risks – Other insurance |
Risks – Health |
|
| Premiums written | 946,679 | 772,787 | 143,713 | 1,097 | 29,082 |
| Premiums ceded | (26,139) | (4,746) | (8,234) | (35) | (13,124) |
| 2021 | ||||||
|---|---|---|---|---|---|---|
| Total | Risks – Motor |
Home Risks | Risks – Other insurance |
Risks – Health |
||
| Premiums written | 907,189 | 748,100 | 131,243 | 1,397 | 26,449 | |
| Premiums ceded | (23,392) | (4,723) | (6,707) | (41) | (11,921) |
No significant events have occurred after the end of 2022 and up to the date of authorisation for issue of these annual accounts.

The year 2022 saw clear signs of a slowdown in global economic activity, due, among other factors, to the ongoing war in Ukraine, high inflation rates and the tightening of monetary policies. However, economic activity held up well, partly due to the buoyancy of the labour markets and the fiscal policy measures rolled out.
Despite the difficult economic conditions throughout the year, the Company achieved net earned reinsurance premiums for the year of 901 million euros, up 2.03% on the previous year. This premium growth was accompanied by a 3.41% increase in the number of customers compared to 2021, reaching 3.5 million customers on the books.
The technical result, however, showed a profit of 68.15 million euros, down 49.16% on the profit obtained in 2021. The main factor behind this decline is the increase in claims incurred during the year to 76.00%, compared to 68.02% in 2021 as a result of inflationary pressures on the cost of claims. The cost of claims was particularly impacted by the marked increase in repair and replacement costs, the higher injury expense and the 13% increase in fatal accidents, plus the ageing of the car population, with a higher claims frequency.
The financial result amounted to 37 million euros, up 13.9% on the previous year, mainly due to the increase in net realised capital gains. These capital gains mainly include gains on foreign currency profiting from the rise in the dollar and gains from the sale of investment funds prior to the introduction of IFRS 9, in order to avoid volatility in the result by recognising changes in valuation through the statement of profit or loss for this type of financial asset. The average rate of return was 2.48% for fixed income securities and 11.55% for equities.
The Company has continued to pursue its investment policy with the aim of guaranteeing the security, liquidity and profitability of its investments, applying principles of dispersion and diversification and ensuring a suitable mix of investment maturities (terms) in respect of the technical liabilities to be covered, in a bid to mitigate market, credit, liquidity and cash flow risks.
The solvency ratio, calculated in accordance with Solvency II regulations, was 188% at the end of 2022, compared to 186% in 2021.
The outlook for 2023 points to a slowdown in growth globally due to high inflation, rising interest rates, reduced investment and disruptions caused by Russia's invasion of Ukraine. The global economy is forecast to grow by 1.7% in 2023 and 2.7% in 2024.
The US Federal Reserve raised the interest rate to 4.5% in December, with the possibility of further hikes. Meanwhile, on 2 February 2023, the ECB increased rates for the fifth consecutive meeting, putting the price of money at 3%, the highest since November 2008. In addition, the ECB is likely to see the need for a further hike and thereafter it is probable that it will evaluate the pace of the increases, depending on macroeconomic data.
With regard to the Spanish market, the Bank of Spain has cut its forecast for GDP in 2023 by 0.1 p.p. to 1.3%, above all as a result of the worsening of the external backdrop. The bank has also revised average GDP growth in 2024 downwards by 0.2 p.p. to 2.7%. This is mainly due to the likely extension in 2023 of some of the measures in force during 2022 to ease the impact of the energy crisis, whose withdrawal at the beginning of 2024 will have a negative impact on activity in the year.
The weakness of consumption due to inflationary pressures and the high level of uncertainty is one of the main factors behind the modest growth in GDP forecast, although it is premature to rule out any scenario in such a volatile context.
The dynamics of Spanish economic activity are expected to remain very weak over the coming months. At the start of 2023 inflationary pressures are expected to remain high, with financial conditions continuing to tighten and confidence levels still low. These conditions are expected to improve in the second half of the year.
Initially, the reduction in inflation will be determined by the energy component. The easing in the pace of food price growth and the fall in the underlying inflation rate will take a little longer to occur.
In a nutshell, 2023 will be a year where the macroeconomic context will continue to impact the Company's business performance, especially in the early stages of the year.
In the Motor Segment, growth is expected to accelerate, although margin pressure will persist, especially in the first part of the year as a result of the inflationary shock. The cost of claims will continue to be impacted by the sharp increase in repair and replacement costs. For 2023 the injury scale includes an 8.5% increase linked to the pension revaluation index.
Real estate market activity continues to grow, although there are signs of slowdown in a context that has caused the Euribor to exceed 3% with the resulting increase in the cost of household mortgage loans. In the Home segment, the Company expects significant growth in its premiums with average premiums rising. The frequency and intensity of weather events will continue to be one of the factors shaping the performance of the ratio of claims incurred in this segment.
The Health segment will continue to consolidate and we expect it to continue to deliver significant growth. The cost of claims will still reflect the increase in healthcare costs and hospital fees.
Finally, the expense figure will be very contained and below the growth of revenues, within the Company's policy of maintaining strict control of overhead expenses.
The Company settles payments to suppliers before the legal deadlines (30 days) and in certain specific cases as per the conditions explicitly agreed upon with the suppliers, without in any case exceeding 60 days. The average payment period to suppliers is 20.82 days.
The Company's Chief Executive Officer and members of the Management Committee are included in an extraordinary remuneration plan of the Group, consisting of the delivery of shares over the three years following the IPO. The purpose of this Plan, which was approved at the General Shareholders' Meeting held on 18 March 2021, is to offer the subjects the possibility of receiving a certain number of shares in the three years following the date of IPO. Of the 13 participants in the Remuneration Plan, 12 are employees of the Company, while one of them is employed by another Group company, namely Línea Directa Asistencia. The main features of the plan are as follows:
The cost of the programme to the Company is recorded as a personnel expense and is offset by a reserve for treasury shares in equity in the balance sheet, which will be cancelled on the three anniversaries when the shares are delivered to the employees.
At 31 December 2021 and 2022, the staff expense accrued and recognised at the Company amounted to € 956 thousand. This allocation was made on the assumption that all plan members would meet the tenure condition on each anniversary.
The value of the incentive to be received in shares of the Company is assessed on the basis of the fair value of the equity instruments allocated at the grant date, considering the terms and conditions of the Plan. The number of equity instruments included when determining the amount of the transaction is adjusted each year through to the vesting date.
The Company had 637,586 treasury shares at 31 December 2022 with which to honour the Group's remuneration plan. Since 29 April 2021, the date of the IPO, on which the Company was awarded 239,678 own shares in the exchange of Bankinter shares, it has made successive acquisitions, all disclosed to the CNMV to complete the complete remuneration plan. The average purchase price of these shares was € 1.57 per share. Some shares were delivered in 2022, while the rest remain in equity.
The Company will deliver the corresponding shares to the employee of the subsidiary Línea Directa Asistencia on the three anniversaries, with the cost being borne by the subsidiary and the Entity receiving cash as consideration for the fair value of the shares delivered.
b) Employee share plans under the Flexible Remuneration programme.
At the end of 2022, employees were offered the opportunity to participate in a share purchase plan as part of their flexible remuneration, which was aimed at all employees of the Company with at least six months' tenure at the Company, excluding members of the Board of Directors.
It was a one-off programme lasting two months (November and December 2022) aimed at facilitating the acquisition of Línea Directa shares among employees through a flexible remuneration programme subject to a beneficial tax regime. The conditions for being able to include the plan in the flexible remuneration programme were as follows: the amount to be allocated would be capped at € 12,000 per year, the shares must be held for three years, and the delivery may not exceed the upper limit for overall remuneration in kind of 30% of the total remuneration, nor may the minimum wage be affected in any way.
The Plan was launched at a 5% discount on the share price. The Plan was approved by the Board of Directors in September and October 2022, following a report by the Appointments, Remuneration and Corporate Governance Committee.
At 31 December 2022, the Company held an interest rate swap (IRS) to hedge against rising interest rates for an initial term of 11 years (two swaps at 31 December 2021 with a term of 15 years). It has been found to be fully compliant with the effectiveness criteria for this type of financial instrument.
There have been no significant events subsequent to the reporting date.
The Company continued to engage in research and development activities in 2022, involving the development of advanced IT applications applied to motor insurance management.
At 31 December 2022 the Company's workforce comprised 1,316 women and 853 men, of whom 32 were employees with a degree of disability equal to or greater than 33%.
In accordance with Order ECO/734/2004 of 11 March, the Línea Directa Customer Service Department and the Consumer Ombudsman have drawn up reports to explain their activities and performance in 2022. These reports are summarised below:
In 2022, a total of 5,809 incidents were handled (6,207 incidents in 2021), 398 (6.85%) of which qualified as complaints (374 (6.03%) complaints in 2021) and 5,411 (93.15%) as claims (5,833 (93.97%) claims in 2021). Of the total, 20.86% related to Policy quoting and management, 69.48% to Accident management and 3.10% to the Roadside assistance service (2021: 23.23%, 68.52% and 2.66%, respectively).
Main issues raised by customers:
Of the total complaints and claims received in 2022, 82.10% (73% in 2021) have been considered estimated and 38.13% valid (35.28% in 2021).
In 2022, a total of 428 cases were heard by the Consumer Ombudsman (801 cases in 2021). A decision was handed down against the insured claimants in 32.94% of these cases, which relate to the following main grievances:
The percentage of decisions delivered in favour of policyholders was up on the previous year, as 67.06% of decisions went with the policyholder in 2022, while in 2021 this figure was 41.82%.
In his report, the Consumer Ombudsman calls for prompter handling of claims so that, between LINEA DIRECTA and the Consumer Ombudsman, they can be resolved ahead of the maximum deadlines prescribed by applicable law and regulations on consumer affairs, pursuant to Royal Legislative Decree 1/2007, of 16 November. He also suggests that the general terms and conditions of the policies, containing their delimitation of risks, exclusions and limitation of liability clauses, should be signed at the same time as the special terms and conditions, whether the product is arranged remotely or via traditional channels.
The Company is exempt from disclosing the non-financial information set out in Law 11/2018, of 28 December, as this information is included in a separate report, namely the "Statement of Consolidated Non-Financial Information – 2022" of the Línea Directa Aseguradora Group, the scope of consolidation of which includes the Company. The consolidated annual accounts, together with the consolidated management report in which this statement is included, will be filed with the Mercantile Registry of Madrid.
For the purposes of Article 538 of the Corporate Enterprises Act, the consolidated Management Report includes the Annual Corporate Governance Report (ACGR), Internal Control over Financial Reporting (ICFR) and the Annual Report on Director Remuneration (ARDR) of Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros, all for the year ended 2022. Both reports are available and can be consulted in full on the website of the Spanish National Securities Market Commission (Comisión Nacional del Mercado de Valores, or CNMV) and on the corporate website.
The Board of Directors of LÍNEA DIRECTA ASEGURADORA, S.A. COMPAÑÍA DE SEGUROS Y REASEGUROS, at its meeting of 23 February 2023, and in compliance with the requirements set out in Article 253 of the Revised Text of the Capital Enterprises Law and Article 37 of the Commercial Code, drew up and authorised for issue the annual financial statements of LINEA DIRECTA ASEGURADORA, S.A. COMPAÑÍA DE SEGUROS Y REASEGUROS and the Management Report contained herein, in relation to financial year 2022.
| Alfonso Botín-Sanz de Sautuola y Naveda Chairman |
Miguel Ángel Merino González Director |
|---|---|
| Rita Estevez Luaña | Elena Otero-Novas Miranda |
| Director | Director |
| John de Zulueta Greenebaum | Ana María Plaza Arregui |
| Director | Director |
| Fernando Masaveu Herrero Director |
Statement to confirm that the above signatures correspond to those of all the members of the Board of Directors of LINEA DIRECTA ASEGURADORA, S.A. COMPAÑÍA DE SEGUROS Y REASEGUROS, all of whom, at the meeting of the Board of Directors held on 23 February 2023, drew up and signed the annual financial statements and management report of LINEA DIRECTA ASEGURADORA, S.A. COMPAÑÍA DE SEGUROS Y REASEGUROS for financial year 2022, in accordance with Article 253 of the Capital Enterprises Law.
Pablo González-Schwitters Grimaldo Secretary to the Board of Directors
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.